8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

February 14, 2012

Date of Report (Date of earliest event reported)

HCP, Inc.

(Exact name of registrant as specified in its charter)

Maryland	001-08895	33-0091377
(State of Incorporation)	(Commission File Number)	(IRS Employer Identification Number)

3760 Kilroy Airport Way

Suite 300

Long Beach, California 90806

(Address of principal executive offices) (Zip Code)

(562) 733-5100

(Registrant’s telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02Results of Operations and Financial Condition.

On February 14, 2012, HCP, Inc. (“HCP”) issued a press release setting forth its financial results for the three months and year ended December 31, 2011. The press release referred to a supplemental information package that is available on HCP’s website, free of charge, at www.hcpi.com. The text of the press release and the supplemental information package are furnished herewith as Exhibits 99.1 and 99.2, respectively, and are specifically incorporated by reference herein.

The information set forth in this Current Report on Form 8-K and the related information in the exhibits attached hereto are being furnished to, and shall not be deemed filed with the Securities Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference into any filing of HCP under the Securities Act of 1933, as amended or the Exchange Act, regardless of any general incorporation language in any filing, except as shall be expressly set forth by specific reference therein.

Item 9.01Financial Statements and Exhibits.

(d)Exhibits.  The following exhibits are being filed herewith:

No.	Description
99.1	Text of the Press Release dated February 14, 2012.
99.2	HCP, Inc. Supplemental Information Package, dated December 31, 2011.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	HCP, Inc.
Date: February 14, 2012	By:	/s/ Timothy M. Schoen
	Name:	Timothy M. Schoen
	Title:	Executive Vice President and Chief Financial Officer

3

EXHIBIT INDEX

No.	Description
99.1	Text of the Press Release dated February 14, 2012.
99.2	HCP, Inc. Supplemental Information Package, dated December 31, 2011.

4

EX-99.1

Exhibit 99.1

FOR IMMEDIATE RELEASE

HCP ANNOUNCES RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2011

FOURTH QUARTER HIGHLIGHTS

--Diluted FFO per share was $0.37, net of a litigation settlement charge; diluted FFO as adjusted per share was $0.67; diluted FAD per share was $0.50; and diluted earnings per share was $0.15

--Year-over-year three-month adjusted NOI Same Property Performance increased 2.2%

--Subsequent to year end:

--  Executed a lease amendment that expands Google’s footprint at our Mountain View campus to a total of 290,000 sq. ft.

--  Completed a $450 million public offering of 3.75% senior unsecured notes due 2019

--  Declared quarterly common stock dividend of $0.50, annualized to $2.00 for 2012, representing a 4.2% increase over 2011 and the 27th consecutive year with a dividend increase

FULL YEAR HIGHLIGHTS

--Diluted FFO per share decreased 3% to $2.19; diluted FFO as adjusted per share increased 21% to $2.69; diluted FAD per share increased 13% to $2.14; and diluted earnings per share increased 29% to $1.29

--Achieved total shareholder returns for one year of 18.7% and two years of 51.3% for periods ending December 31, 2011

--Year-over-year adjusted NOI Same Property Performance increased 4.0%

--Completed 2.8 million sq. ft. of medical office and life science leasing with a retention rate of 75%, resulting in an increase in occupancy to 91%

--Closed $7.0 billion of investments, led by our $6.1 billion acquisition of HCR ManorCare’s real estate assets, for which we replaced the stock consideration due to the seller valued at $33.14 per share with cash

--    Executed five senior housing loan commitments to fund a total of $101 million of construction financing

--    Accessed the public markets to raise over $3.7 billion in capital and renewed our $1.5 billion revolving line of credit facility

--Obtained credit upgrades from Fitch and Moody’s and placed on positive credit watch by S&P

--Received $330 million from the early payoff of our Genesis debt investments, realizing a 40% annualized internal rate of return

--Continued to lead in sustainability as recognized by the U.S. Environmental Protection Agency and NAREIT

Page 1 of 11

LONG BEACH, CA, February 14, 2012 -- HCP (the “Company” or “we”) (NYSE:HCP) announced results for the fourth quarter and year ended December 31, 2011 as follows (in thousands, except per share amounts):

Fourth Quarter Comparison

	Three Months Ended December 31, 2011				Three Months Ended December 31, 2010				Per Share
	Amount		Per Share		Amount		Per Share		Change
FFO	$	150,578	$	0.37	$	202,611	$	0.62	$	(0.25	)
Litigation settlement charge(1)	125,000		0.30		—		—		0.30
Merger-related items(2)	—		—		4,339		0.02		(0.02		)
FFO as adjusted	$	275,578	$	0.67	$	206,950	$	0.64	$	0.03
FAD	$	202,890	$	0.50	$	171,292	$	0.53	$	(0.03	)
Net income applicable to common shares	$	61,996	$	0.15	$	136,202	$	0.42	$	(0.27	)

(1)  This charge during the quarter ended December 31, 2011 relates to the Ventas, Inc. (“Ventas”) litigation settlement. See the “Litigation” section of this release for additional information regarding this settlement.

(2)  See the “Funds From Operations” section of this release for additional information regarding merger-related items.

In addition to the litigation settlement charge, operating results for the quarter ended December 31, 2011, include the negative impact of $0.01 per share for the write-down in the carrying value of a marketable security. In addition to the merger-related items, operating results for the quarter ended December 31, 2010, include the positive impact of $0.06 per share from the following: (i) other income of $0.03 per share related to gain on sales of marketable securities and (ii) interest income of $0.03 per share from the early repayment of a mortgage loan receivable.

Full Year Comparison

	Year Ended December 31, 2011				Year Ended December 31, 2010						Per Share
	Amount		Per Share		Amount			Per Share			Change
FFO(1)	$	877,907	$	2.19	$	690,637		$	2.25		$	(0.06	)
Litigation settlement charge(2)	125,000		0.31		—			—			0.31
Other impairments (recoveries)(3)	15,400		0.04		(11,900		)	(0.04		)	0.08
Merger-related items(3)	26,596		0.15		4,339			0.02			0.13
FFO as adjusted	$	1,044,903	$	2.69	$	683,076		$	2.23		$	0.46
FAD	$	830,651	$	2.14	$	578,452		$	1.89		$	0.25
Net income applicable to common shares	$	515,302	$	1.29	$	307,498		$	1.00		$	0.29

(1)  NAREIT recently issued updated reporting guidance that directs companies, for their computation of NAREIT FFO, to exclude impairments of depreciable real estate and other assets when write-downs are driven by measurable decreases in the fair value of real estate holdings (e.g., investments in joint ventures that primarily hold real estate). Previously, the Company’s calculation of FFO (consistent with NAREIT’s previous guidance) did not exclude impairments of, or related to, depreciable real estate. Consistent with this current NAREIT reporting guidance, the Company has restated its 2010 FFO amounts.

(2)  This charge during the year ended December 31, 2011 relates to the Ventas litigation settlement. See the “Litigation” section of this release for additional information regarding this settlement.

(3)  See the “Funds From Operations” section of this release for additional information regarding impairments or recoveries of non-depreciable assets (“other impairments”) and merger-related items.

FFO, FFO as adjusted and FAD are supplemental non-GAAP financial measures that the Company believes are helpful in evaluating the operating performance of real estate investment trusts. See the “Funds From Operations” section of this release for additional information regarding FFO and FFO as adjusted and the “Funds Available for Distribution” section for additional information regarding FAD.

INVESTMENT TRANSACTIONS

During the quarter ended December 31, 2011, we made investments of $40 million to fund development and other capital projects, primarily in our life science and medical office segments. During the quarter ended December 31, 2011, we executed two loan commitments to fund up to $35 million of senior housing development.

During the three months ended December 31, 2011, we sold three senior housing facilities for $19 million, recognizing gain on sales of real estate of $3.1 million.

Page 2 of 11

LITIGATION

On November 9, 2011, we entered into an agreement with Ventas, Inc. to settle all remaining claims relating to Ventas’s litigation against HCP arising out of Ventas’s 2007 acquisition of Sunrise Senior Living REIT. We paid $125 million to Ventas and incurred a charge during the quarter ended December 31, 2011 for the amount paid.

SUSTAINABILITY

HCP’s 2011 sustainability accomplishments include the following: (i) earned 29 ENERGY STAR certifications in its medical office (17), life science (7) and senior housing (5) segments; (ii) recognized in May 2011 by ENERGY STAR as the leader in ENERGY STAR certifications for the MOB category; and (iii) awarded NAREIT’s “Leader in the Light” Innovator Award, which recognizes companies demonstrating excellence in energy efficiency.

FINANCING

On January 23, 2012, we issued $450 million of 3.75% senior unsecured notes due 2019; net proceeds from the offering were $444 million.

OTHER EVENTS

On February 7, 2012, we executed a lease amendment with Google to expand its footprint at our Mountain View campus to a total of 290,000 sq. ft. Under the terms of this amendment, Google will: (i) lease an additional 41,000 sq. ft. building for a term of 10 years, resulting in a mark-to-market rent increase of 17%; and (ii) extend the term on 124,000 sq. ft. through 2022 (coterminous with the expansion). The terms of the remaining 125,000 sq. ft. leased to 2021 were unchanged.

DIVIDEND

On January 26, 2012, we announced that our Board of Directors declared a quarterly cash dividend of $0.50 per common share. The dividend will be paid on February 22, 2012 to stockholders of record as of the close of business on February 6, 2012. The annualized distribution rate for 2012 is $2.00, compared to $1.92 for 2011, which represents an increase of 4.2%.

OUTLOOK

For the full year 2012, we expect FFO applicable to common shares to range between $2.70 and $2.76 per share; FAD applicable to common shares to range between $2.14 and $2.20 per share; and net income applicable to common shares to range between $1.81 and $1.87 per share. These estimates do not reflect, among other things, the potential impact of future acquisitions or dispositions. See Projected Future Operations section of this release for additional information regarding these estimates.

COMPANY INFORMATION

HCP has scheduled a conference call and webcast for Tuesday, February 14, 2012 at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) in order to present the Company’s performance and operating results for the quarter and year ended December 31, 2011. The conference call is accessible by dialing (877) 724-7556 (U.S.) or (706) 645-4695 (International). The participant passcode is 42163539. The webcast is accessible via the Company’s website at www.hcpi.com. This link can be found on the “Event Calendar” page, which is under the “Investor Relations” tab. Through February 28, 2012, an archive of the webcast will be available on our website and a telephonic replay can be accessed by calling (855) 859-2056 (U.S.) or (404) 537-3406 (International) and entering passcode 42163539. The Company’s supplemental information package for the current period will also be available on the Company’s website in the “Presentations” section of the “Investor Relations” tab.

ABOUT HCP

HCP, Inc. (NYSE:HCP) is a fully integrated real estate investment trust (REIT) that invests primarily in real estate serving the healthcare industry in the United States. The Company’s portfolio of assets is diversified among five distinct sectors: senior housing, post-acute/skilled nursing, life science, medical office and hospitals. A publicly traded company since 1985, HCP: (i) was the first healthcare REIT selected to the S&P 500 index; (ii) has increased its dividend per share for 27 consecutive years; and (iii) is the only REIT included in the S&P 500 Dividend Aristocrats index. For more information regarding HCP, visit the Company’s website at www.hcpi.com.

###

Page 3 of 11

FORWARD-LOOKING STATEMENTS

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this release which are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements include among other things, net income applicable to common shares on a diluted basis, FFO applicable to common shares on a diluted basis, and FAD applicable to common shares on a diluted basis for the full-year of 2012.  These statements are made as of the date hereof, are not guarantees of future performance and are subject to known and unknown risks, uncertainties, assumptions and other factors—many of which are out of the Company and its management’s control and difficult to forecast—that could cause actual results to differ materially from those set forth in or implied by such forward-looking statements.  These risks and uncertainties include but are not limited to: national and local economic conditions; continued volatility in the capital markets, including changes in interest rates and the availability and cost of capital, which changes and volatility affect opportunities for profitable investments; the Company’s ability to access external sources of capital when desired and on reasonable terms; the Company’s ability to manage its indebtedness levels; changes in the terms of the Company’s indebtedness; the Company’s ability to maintain its credit ratings; the potential impact of existing and future litigation matters, including the possibility of larger than expected litigation costs and related developments; the Company’s ability to successfully integrate the operations of acquired companies; risks associated with the Company’s investments in joint ventures and unconsolidated entities, including its lack of sole decision-making authority and its reliance on its joint venture partners’ financial condition and continued cooperation; competition for lessees and mortgagors (including new leases and mortgages and the renewal or rollover of existing leases); the Company’s ability to reposition its properties on the same or better terms if existing leases are not renewed or the Company exercises its right to replace an existing operator or tenant upon default; continuing reimbursement uncertainty in the post-acute/skilled nursing segment; competition in the senior housing segment specifically and in the healthcare industry in general; the ability of the Company’s operators and tenants from its senior housing segment to maintain or increase their occupancy levels and revenues; the ability of the Company’s lessees and mortgagors to maintain the financial strength and liquidity necessary to satisfy their respective obligations to the Company and other third parties; the bankruptcy, insolvency or financial deterioration of the Company’s operators, lessees, borrowers or other obligors; changes in healthcare laws and regulations, including the impact of future or pending healthcare reform, and other changes in the healthcare industry which affect the operations of the Company’s lessees or obligors, including changes in the federal budget resulting in the reduction or nonpayment of Medicare or Medicaid reimbursement rates; the Company’s ability to recruit and retain key management personnel; costs of compliance with regulations and environmental laws affecting the Company’s properties; changes in tax laws and regulations; changes in the financial position or business strategies of HCR ManorCare; the Company’s ability and willingness to maintain its qualification as a REIT due to economic, market, legal, tax or other considerations; changes in rules governing financial reporting, including new accounting pronouncements; and other risks described from time to time in the Company’s Securities and Exchange Commission filings. The Company assumes no, and hereby disclaims any, obligation to update any of the foregoing or any other forward-looking statements as a result of new information or new or future developments, except as otherwise required by law.

CONTACT

HCP

Timothy M. Schoen

Executive Vice President and Chief Financial Officer

(562) 733-5309

Page 4 of 11

HCP, Inc.

Consolidated Balance Sheets

In thousands, except share and per share data

(Unaudited)

	December 31,			December 31,
	2011			2010
Assets
Real estate:
Buildings and improvements	$	8,937,492		$	8,189,309
Development costs and construction in progress	190,590			144,116
Land	1,731,327			1,572,744
Accumulated depreciation and amortization	(1,473,977		)	(1,245,996		)
Net real estate	9,385,432			8,660,173
Net investment in direct financing leases	6,727,777			609,661
Loans receivable, net	110,253			2,002,866
Investments in and advances to unconsolidated joint ventures	224,052			195,847
Accounts receivable, net of allowance of $1,341 and $5,150, respectively	26,681			34,504
Cash and cash equivalents	33,506			1,036,701
Restricted cash	41,553			36,319
Intangible assets, net	373,763			316,375
Real estate held for sale, net	—			16,591
Other assets, net	485,458			422,886
Total assets	$	17,408,475		$	13,331,923
Liabilities and equity
Bank line of credit	$	454,000		$	—
Senior unsecured notes	5,416,063			3,318,379
Mortgage debt	1,764,571			1,235,779
Other debt	87,985			92,187
Intangible liabilities, net	124,142			148,072
Accounts payable and accrued liabilities	275,478			313,806
Deferred revenues	65,614			77,653
Total liabilities	8,187,853			5,185,876
Preferred stock, $1.00 par value: 50,000,000 shares authorized; 11,820,000 shares issued and outstanding, liquidation preference of $25.00 per share	285,173			285,173
Common stock, $1.00 par value: 750,000,000 shares authorized; 408,629,444 and 370,924,887 shares issued and outstanding, respectively	408,629			370,925
Additional paid-in capital	9,383,536			8,089,982
Cumulative dividends in excess of earnings	(1,024,274		)	(775,476		)
Accumulated other comprehensive loss	(19,582		)	(13,237		)
Total stockholders’ equity	9,033,482			7,957,367
Joint venture partners	16,971			14,935
Non-managing member unitholders	170,169			173,745
Total noncontrolling interests	187,140			188,680
Total equity	9,220,622			8,146,047
Total liabilities and equity	$	17,408,475		$	13,331,923

Page 5 of 11

HCP, Inc.

Consolidated Statements of Income

In thousands, except per share data

(Unaudited)

	Three Months Ended December 31,						Year Ended December 31,
	2011			2010			2011			2010
Revenues:
Rental and related revenues	$	248,521		$	236,522		$	1,015,867		$	917,579
Tenant recoveries	22,494			21,856			92,259			89,012
Resident fees and services	35,305			17,318			50,619			32,596
Income from direct financing leases	154,151			12,200			464,704			49,438
Interest income	665			52,159			99,864			160,163
Investment management fee income	468			911			2,073			4,666
Total revenues	461,604			340,966			1,725,386			1,253,454
Costs and expenses:
Depreciation and amortization	87,362			77,820			356,834			311,218
Interest expense	101,433			68,354			419,337			288,650
Operating	69,049			58,341			220,172			210,202
General and administrative	19,678			18,008			96,150			83,048
Litigation settlement	125,000			—			125,000			—
Impairments (recoveries)	—			—			15,400			(11,900		)
Total costs and expenses	402,522			222,523			1,232,893			881,218
Other income (expense), net	(4,720		)	8,667			12,338			15,818
Income before income taxes and equity income from and impairments of investments in unconsolidated joint ventures	54,362			127,110			504,831			388,054
Income taxes	(960		)	1,397			(1,249		)	(412		)
Equity income from unconsolidated joint ventures	13,952			692			46,750			4,770
Impairments of investments in unconsolidated joint ventures	—			—			—			(71,693		)
Income from continuing operations	67,354			129,199			550,332			320,719
Discontinued operations:
Income before gain on sales of real estate, net of income taxes	326			454			1,055			3,751
Gain on sales of real estate, net of income taxes	3,107			15,873			3,107			19,925
Total discontinued operations	3,433			16,327			4,162			23,676
Net income	70,787			145,526			554,494			344,395
Noncontrolling interests’ share in earnings	(2,943		)	(3,609		)	(15,603		)	(13,686		)
Net income attributable to HCP, Inc.	67,844			141,917			538,891			330,709
Preferred stock dividends	(5,282		)	(5,282		)	(21,130		)	(21,130		)
Participating securities’ share in earnings	(566		)	(433		)	(2,459		)	(2,081		)
Net income applicable to common shares	$	61,996		$	136,202		$	515,302		$	307,498
Basic earnings per common share:
Continuing operations	$	0.14		$	0.37		$	1.28		$	0.93
Discontinued operations	0.01			0.05			0.01			0.08
Net income applicable to common shares	$	0.15		$	0.42		$	1.29		$	1.01
Diluted earnings per common share:
Continuing operations	$	0.14		$	0.37		$	1.28		$	0.92
Discontinued operations	0.01			0.05			0.01			0.08
Net income applicable to common shares	$	0.15		$	0.42		$	1.29		$	1.00
Weighted average shares used to calculate earnings per common share:
Basic	407,907			324,361			398,446			305,574
Diluted	409,730			325,985			400,218			306,900

Page 6 of 11

HCP, Inc.

Consolidated Statements of Cash Flows

In thousands

(Unaudited)

	Year Ended December 31,
	2011			2010
Cash flows from operating activities:
Net income	$	554,494		$	344,395
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of real estate, in-place lease and other intangibles:
Continuing operations	356,834			311,218
Discontinued operations	561			2,229
Amortization of above and below market lease intangibles, net	(4,510		)	(6,378		)
Amortization of deferred compensation	20,034			14,924
Amortization of debt premiums, discounts and issuance costs, net	25,769			9,856
Straight-line rents	(59,173		)	(47,243		)
Loan and direct financing lease interest accretion	(93,003		)	(69,645		)
Deferred rental revenues	(2,319		)	(3,984		)
Equity income from unconsolidated joint ventures	(46,750		)	(4,770		)
Distributions of earnings from unconsolidated joint ventures	3,273			5,373
Gain upon consolidation of joint venture	(7,769		)	—
Marketable securities (gains) losses, net	5,396			(14,597		)
Gain upon settlement of loans receivable	(22,812		)	—
Gain on sale of real estate	(3,107		)	(19,925		)
Derivative (gains) losses, net	(1,226		)	1,302
Impairments, net of recoveries	15,400			59,793
Changes in:
Accounts receivable, net	2,590			9,222
Other assets	27,582			(6,341		)
Accounts payable and accrued liabilities	(47,103		)	(4,931		)
Net cash provided by operating activities	724,161			580,498
Cash flows from investing activities:
Cash used in the HCR ManorCare Acquisition, net of cash acquired	(4,026,556		)	—
Cash used in the HCP Ventures II purchase, net of cash acquired	(135,550		)	—
Other acquisitions and development of real estate	(198,385		)	(304,847		)
Leasing costs and tenant and capital improvements	(52,903		)	(97,930		)
Proceeds from sales of real estate, net	19,183			32,284
Purchase of an interest in and contributions to unconsolidated joint ventures	(95,000		)	(6,565		)
Distributions in excess of earnings from unconsolidated joint ventures	2,408			4,365
Purchases of marketable equity securities	(22,449		)	—
Proceeds from the sales of marketable securities	—			179,215
Principal repayments on loans receivable and direct financing leases	303,941			63,953
Investments in loans receivable	(369,939		)	(298,085		)
Increase in restricted cash	(5,234		)	(3,319		)
Net cash used in investing activities	(4,580,484		)	(430,929		)
Cash flows from financing activities:
Net borrowings under bank line of credit	454,000			—
Repayment of term loan	—			(200,000		)
Issuance of senior unsecured notes	2,400,000			—
Repayment of senior unsecured notes	(292,265		)	(206,422		)
Repayments of mortgage and other secured debt	(169,783		)	(636,096		)
Debt discounts and issuance costs	(43,716		)	(11,850		)
Net proceeds from the issuance of common stock and exercise of options	1,327,813			2,426,900
Dividends paid on common and preferred stock	(787,689		)	(590,735		)
Sale of noncontrolling interests	14,087			8,395
Purchase of noncontrolling interests	(34,104		)	—
Distributions to noncontrolling interests	(15,215		)	(15,319		)
Net cash provided by financing activities	2,853,128			774,873
Net increase (decrease) in cash and cash equivalents	(1,003,195		)	924,442
Cash and cash equivalents, beginning of year	1,036,701			112,259
Cash and cash equivalents, end of year	$	33,506		$	1,036,701

Page 7 of 11

HCP, Inc.

Funds From Operations(1)

In thousands, except per share data

(Unaudited)

	Three Months Ended December 31,						Year Ended December 31,
	2011			2010			2011			2010(2)
Net income applicable to common shares	$	61,996		$	136,202		$	515,302		$	307,498
Depreciation and amortization of real estate, in-place lease and other intangibles:
Continuing operations	87,362			77,820			356,834			311,218
Discontinued operations	5			237			561			2,229
Direct financing lease (“DFL”) depreciation	2,961			—			8,840			—
Gain on sales of real estate	(3,107		)	(15,873		)	(3,107		)	(19,925		)
Gain upon consolidation of joint venture	—			—			(7,769		)	—
Impairments of investments in joint ventures	—			—			—			71,693
Equity income from unconsolidated joint ventures	(13,952		)	(692		)	(46,750		)	(4,770		)
FFO from unconsolidated joint ventures	16,479			5,579			56,887			25,288
Noncontrolling interests’ and participating securities’ share in earnings	3,509			4,042			18,062			15,767
Noncontrolling interests’ and participating securities’ share in FFO	(4,675		)	(4,704		)	(20,953		)	(18,361		)
FFO applicable to common shares	$	150,578		$	202,611		$	877,907		$	690,637
Distributions on dilutive convertible units	—			2,987			6,916			11,847
Diluted FFO applicable to common shares	$	150,578		$	205,598		$	884,823		$	702,484
Diluted FFO per common share	$	0.37		$	0.62		$	2.19		$	2.25
Weighted average shares used to calculate diluted FFO per share	409,730			331,960			403,864			312,797
Impact of adjustments to FFO:
Litigation settlement charge(3)	$	125,000		$	—		$	125,000		$	—
Other impairments (recoveries)(4)	—			—			15,400			(11,900		)
Merger-related items(5)	—			4,339			26,596			4,339
	$	125,000		$	4,339		$	166,996		$	(7,561	)
FFO as adjusted applicable to common shares	$	275,578		$	206,950		$	1,044,903		$	683,076
Distributions on dilutive convertible units and other	2,858			2,970			11,646			12,089
Diluted FFO as adjusted applicable to common shares	$	278,436		$	209,920		$	1,056,549		$	695,165
Per common share impact of adjustments on diluted FFO (3)(4)(5)	$	0.30		$	0.02		$	0.50		$	(0.02	)
Diluted FFO as adjusted per common share	$	0.67		$	0.64		$	2.69		$	2.23
Weighted average shares used to calculate diluted FFO as adjusted per share	415,624			325,960			393,237			311,285

(1) The Company believes FFO is an important supplemental measure of operating performance for a real estate investment trust. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a real estate investment trust that uses historical cost accounting for depreciation could be less informative. The term FFO was designed by the real estate investment trust industry to address this issue. FFO is defined as net income applicable to common shares (computed in accordance with U.S. generally accepted accounting principles or “GAAP”), excluding gains or losses from acquisition and dispositions of depreciable real estate or related interests, impairments of, or related to, depreciable real estate, plus real estate and DFL depreciation and amortization, with adjustments for joint ventures. Adjustments for joint ventures are calculated to reflect FFO on the same basis. FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income. The Company’s computation of FFO may not be comparable to FFO reported by other real estate investment trusts that do not define the term in accordance with the current National Association of Real Estate Investment Trusts’ (“NAREIT”) definition or that have a different interpretation of the current NAREIT definition from the Company. FFO as adjusted represents FFO before the impact of litigation settlement charges, other impairments, other impairment recoveries and merger-related items (defined below). Management believes FFO as adjusted is a useful alternative measurement. This measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net income.

(2)NAREIT recently issued updated reporting guidance that directs companies, for their computation of NAREIT FFO, to exclude impairments of depreciable real estate and other assets when write-downs are driven by measurable decreases in the fair value of real estate holdings (e.g., investments in joint ventures that primarily hold real estate). Previously, the Company’s calculation of FFO (consistent with NAREIT’s previous guidance) did not exclude impairments of, or related to, depreciable real estate. Consistent with this current NAREIT reporting guidance, the Company has restated its 2010 FFO amounts.

(3)This charge of $125 million, or $0.31 per share, during the year ended December 31, 2011 relates to the Ventas settlement. See the “Litigation” section of this release for additional information regarding this settlement.

(4)Other impairments of $15.4 million, or $0.04 per share, during the year ended December 31, 2011 relates to our senior secured loan to Cirrus Health. Recoveries of $11.9 million, or $0.04 per share, relate to portions of previous impairment charges related to investments in three direct financing leases (non-depreciable due to lessee purchase option) and a participation interest in a senior construction loan related to Erickson Retirement Communities.

(5)2011 merger-related items represents the aggregate impact of $0.15 per share include the following: (i) direct transaction costs, (ii) prefunding activities related to the impact of senior unsecured notes and common stock issued to prefund the HCR ManorCare Acquisition, partially offset by (iii) income related to gains upon the reinvestment of the Company’s debt investment in HCR ManorCare and other miscellaneous items. 2010 merger-related items of $0.02 per share include the following: (i) direct transaction costs; and (ii) prefunding activities related to the impact of common stock issued to prefund the HCR ManorCare Acquisition.

Page 8 of 11

HCP, Inc.

Funds Available for Distribution(1)

In thousands, except per share data

(Unaudited)

	Three Months Ended December 31,						Year Ended December 31,
	2011			2010			2011			2010
FFO as adjusted applicable to common shares	$	275,578		$	206,950		$	1,044,903		$	683,076
Amortization of above and below market lease intangibles, net	(1,239		)	(1,041		)	(4,510		)	(6,378		)
Amortization of deferred compensation (stock-based)	4,748			3,618			20,034			14,924
Amortization of debt premiums, discounts and issuance costs, net(2)	3,651			1,840			13,716			9,078
Straight-line rents	(12,237		)	(14,374		)	(59,173		)	(47,243		)
DFL accretion(3)	(25,499		)	(2,300		)	(74,007		)	(10,641		)
DFL depreciation	(2,961		)	—			(8,840		)	—
Deferred revenues – tenant improvement related	(237		)	(929		)	(2,371		)	(3,714		)
Deferred revenues – additional rents (SAB 104)	(798		)	(810		)	52			(270		)
Leasing costs and tenant and capital improvements(4)	(21,131		)	(20,853		)	(52,903		)	(54,237		)
Joint venture and other FAD adjustments(3)	(16,985		)	(809		)	(46,250		)	(6,143		)
FAD applicable to common shares	$	202,890		$	171,292		$	830,651		$	578,452
Distributions on dilutive convertible units	1,758			1,714			6,916			6,676
Diluted FAD applicable to common shares	$	204,648		$	173,006		$	837,567		$	585,128
Diluted FAD per common share	$	0.50		$	0.53		$	2.14		$	1.89
Weighted average shares used to calculate diluted FAD per common share	413,338			323,644			390,944			308,953

(1) Funds Available for Distribution (“FAD”) is defined as FFO as adjusted after excluding the impact of the following: (i) straight-line rents; (ii) amortization of acquired above/below market lease intangibles; (iii) amortization of debt premiums, discounts and issuance costs; (iv) amortization of stock—based compensation expense; (v) accretion and depreciation related to direct financing leases; and (vi) deferred revenues. Further, FAD is computed after deducting recurring capital expenditures, including leasing costs and second generation tenant and capital improvements and includes similar adjustments to compute the Company’s share of FAD from its unconsolidated joint ventures. Other REITs or real estate companies may use different methodologies for calculating FAD, and accordingly, HCP’s FAD may not be comparable to those reported by other REITs. Although HCP’s FAD computation may not be comparable to that of other REITs, management believes FAD provides a meaningful supplemental measure of the Company’s ability to fund its ongoing dividend payments. In addition, management believes that in order to further understand and analyze the Company’s liquidity, FAD should be compared with cash flows as determined in accordance with GAAP and presented in its consolidated financial statements. FAD does not represent cash generated from operating activities determined in accordance with GAAP, and FAD should not be considered as an alternative to net income (determined in accordance with GAAP) as an indication of the Company’s performance, as an alternative to net cash flows from operating activities (determined in accordance with GAAP), or as a measure of the Company’s liquidity.

(2) Excludes $11.3 million related to the write-off of unamortized loan fees related to an expired bridge loan commitment and $0.8 million related to the amortization of deferred issuance costs of the senior notes, which costs are included in merger-related items for the year ended December 31, 2011.

(3) For the quarter and year ended December 31, 2011, DFL accretion reflects an elimination of $14.5 million and $42.2 million respectively. Our ownership interest in HCR ManorCare OpCo is accounted for using the equity method, which requires an ongoing elimination of DFL income that is proportional to our ownership in HCR ManorCare OpCo. Further, our share of earnings from HCR ManorCare OpCo (equity income) increases for the corresponding elimination of related lease expense recognized at the HCR ManorCare OpCo level, which we present as a non-cash joint venture FAD adjustment.

(4) Excludes $41 million ($2 million in 4Q2010 and $39 million in 3Q2010) of deferred leasing costs related to the buyout of management contracts for 27 Sunrise-managed communities. On November 1, 2010, we exercised our rights to terminate management contracts relating to 27 senior housing communities previously operated by Sunrise; our net investment to acquire these termination rights was $41 million, which consisted of a $50 million payment to Sunrise that was partially offset for certain working capital acquired in conjunction with this transaction.

Page 9 of 11

HCP, Inc.

Net Operating Income and Same Property Performance(1)(2)

Dollars in thousands

(Unaudited)

	Three Months Ended December 31,						Year Ended December 31,
	2011			2010			2011			2010
Net income	$	70,787		$	145,526		$	554,494		$	344,395
Interest income	(665		)	(52,159		)	(99,864		)	(160,163		)
Investment management fee income	(468		)	(911		)	(2,073		)	(4,666		)
Depreciation and amortization	87,362			77,820			356,834			311,218
Interest expense	101,433			68,354			419,337			288,650
General and administrative	19,678			18,008			96,150			83,048
Litigation settlement	125,000			—			125,000			—
Impairments (recoveries)	—			—			15,400			(11,900		)
Other (Income) expense, net	4,720			(8,667		)	(12,338		)	(15,818		)
Income taxes	960			(1,397		)	1,249			412
Equity income from unconsolidated joint ventures	(13,952		)	(692		)	(46,750		)	(4,770		)
Impairments of investments in unconsolidated joint ventures	—			—			—			71,693
Total discontinued operations, net of income taxes	(3,433		)	(16,327		)	(4,162		)	(23,676		)
NOI(1)	$	391,422		$	229,555		$	1,403,277		$	878,423
Straight-line rents	(12,237		)	(14,374		)	(59,173		)	(47,243		)
DFL accretion	(25,499		)	(2,300		)	(74,007		)	(10,641		)
Amortization of above and below market lease intangibles, net	(1,239		)	(1,041		)	(4,510		)	(6,378		)
Lease termination fees	(2,457		)	(2,500		)	(5,873		)	(7,665		)
NOI adjustments related to discontinued operations	—			—			—			27
Adjusted NOI(1)	$	349,990		$	209,340		$	1,259,714		$	806,523
Non-SPP adjusted NOI(1)(2)	(133,519		)	2,400			(422,158		)	(955		)
Same property portfolio adjusted NOI(1)(2)	$	216,471		$	211,740		$	837,556		$	805,568
Adjusted NOI % change – SPP	2.2		%				4.0		%

(1) The Company believes Net Operating Income from Continuing Operations (“NOI”) provides investors relevant and useful information because it measures the operating performance of the Company’s leased properties (i.e., real estate and DFLs) at the property level on an unleveraged basis. NOI is used to evaluate the operating performance of leased properties and SPP. The Company uses NOI and NOI, as adjusted, to make decisions about resource allocations, to assess and compare property level performance, and evaluate SPP. The Company believes that net income is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income as defined by GAAP since it does not reflect the aforementioned excluded items. Further, NOI may not be comparable to that of other real estate investment trusts, as they may use different methodologies for calculating NOI.

NOI is defined as rental revenues, including tenant reimbursements, resident fees and services, and income from direct financing leases, less property level operating expenses. NOI excludes interest income, investment management fee income, depreciation and amortization, interest expense, general and administrative expenses, litigation settlement, impairments, impairment recoveries, other income, net, income tax expenses, equity income from unconsolidated joint ventures and discontinued operations. NOI, as adjusted, is calculated as NOI eliminating the effects of straight-line rents, DFL accretion, amortization of above and below market lease intangibles, and lease termination fees. NOI, as adjusted, is sometimes referred to as “adjusted NOI” or “cash NOI.”

(2) Same property statistics allow management to evaluate the performance of the Company’s leased property portfolio under a consistent population, which eliminates the changes in the composition of our portfolio of properties. The Company identifies its SPP as stabilized properties that are, and remained, in operations for the duration of the year-over-year comparison periods presented. Accordingly, it takes a stabilized property a minimum of 12 months in operations to be included in the Company’s same property portfolio. SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis.

Page 10 of 11

HCP, Inc.

Projected Future Operations(1)

(Unaudited)

	Full Year 2012
	Low			High
Diluted earnings per common share	$	1.81		$	1.87
Real estate depreciation and amortization	0.85			0.85
DFL depreciation	0.03			0.03
Joint venture FFO adjustments	0.01			0.01
Diluted FFO per common share	$	2.70		$	2.76
Amortization of net below market lease intangibles and deferred revenues	(0.01		)	(0.01		)
Stock-based compensation	0.05			0.05
Amortization of debt premiums, discounts and issuance costs, net	0.04			0.04
Straight-line rents	(0.10		)	(0.10		)
DFL accretion(2)	(0.23		)	(0.23		)
DFL depreciation	(0.03		)	(0.03		)
Leasing costs and tenant and capital improvements	(0.14		)	(0.14		)
Joint venture and other FAD adjustments(2)	(0.14		)	(0.14		)
Diluted FAD per common share	$	2.14		$	2.20

(1)Except as otherwise noted above, the foregoing projections reflect management’s view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, development items and the earnings impact of the events referenced in this release. Except as otherwise noted, these estimates do not reflect the potential impact of future acquisitions, dispositions, other impairments or recoveries, the future bankruptcy or insolvency of the Company’s operators, lessees, borrowers or other obligors, the effect of any future restructuring of the Company’s contractual relationships with such entities, gains or losses on marketable securities, ineffectiveness related to our cash flow hedges, offerings of debt or existing and future litigation matters including the possibility of larger than expected litigation costs and related developments. There can be no assurance that the Company’s actual results will not differ materially from the estimates set forth above. The aforementioned ranges represent management’s best estimate of results based upon the underlying assumptions as of the date of this press release. Except as otherwise required by law, management assumes no, and hereby disclaims any, obligation to update any of the foregoing projections as a result of new information or new or future developments.

(2)Our ownership interest in HCR ManorCare OpCo is accounted for using the equity method, which requires an ongoing elimination of DFL income that is proportional to our ownership in HCR ManorCare OpCo. Further, our share of earnings from HCR ManorCare OpCo (equity income) increases for the corresponding elimination of related lease expense recognized at the HCR ManorCare OpCo level, which we present as a non-cash joint venture FAD adjustment..

Page 11 of 11

EX-99.2

Exhibit 99.2

Supplemental Information

December 31, 2011

(Unaudited)

South San Francisco, CA	Sarasota, FL
Tiverton, RI	Elk Grove, CA

Table of Contents

Company Information	1
Summary	2
Funds From Operations	3
Funds Available for Distribution	4
Capitalization	5
Credit Profile	6
Indebtedness and Ratios	7
Investments and Dispositions	8
Development	9
Owned Portfolio
Portfolio summary	10
Portfolio concentrations	11
Same property portfolio	12
Lease expirations and debt investment maturities	13
Owned Senior Housing Portfolio
Investments and operator concentration	14
Trends	15
Owned Post-Acute/Skilled Nursing Portfolio
Investments and operator concentration	16
Trends and HCR ManorCare information	17
Owned Life Science Portfolio
Investments, tenant concentration and trends	18
Selected lease expirations and leasing activity	19
Owned Medical Office Portfolio
Investments and trends	20
Leasing activity	21
Owned Hospital Portfolio
Investments and operator concentration	22
Trends	23
Investment Management Platform
Summary and balance sheets	24
Statements of operations and funds from operations	25
Net operating income	26
Portfolio summary	27
Reporting Definitions and Reconciliations of Non-GAAP Measures	28-33

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this supplemental information which are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements include among other things the Company’s estimate of (i) completion dates, stabilization dates, rentable square feet and total investment for development projects in progress, and (ii) rentable square feet for land held for development.  These statements are made as of the date hereof, are not guarantees of future performance and are subject to known and unknown risks, uncertainties, assumptions and other factors—many of which are out of the Company and its management’s control and difficult to forecast—that could cause actual results to differ materially from those set forth in or implied by such forward-looking statements.  These risks and uncertainties include but are not limited to: national and local economic conditions; continued volatility in the capital markets, including changes in interest rates and the availability and cost of capital, which changes and volatility affect opportunities for profitable investments; the Company’s ability to access external sources of capital when desired and on reasonable terms; the Company’s ability to manage its indebtedness levels; changes in the terms of the Company’s indebtedness; the Company’s ability to maintain its credit ratings; the potential impact of existing and future litigation matters, including the possibility of larger than expected litigation costs and related developments; the Company’s ability to successfully integrate the operations of acquired companies; risks associated with the Company’s investments in joint ventures and unconsolidated entities, including its lack of sole decision-making authority and its reliance on its joint venture partners’ financial condition and continued cooperation; competition for lessees and mortgagors (including new leases and mortgages and the renewal or rollover of existing leases); the Company’s ability to reposition its properties on the same or better terms if existing leases are not renewed or the Company exercises its right to replace an existing operator or tenant upon default; continuing reimbursement uncertainty in the post-acute/skilled nursing segment; competition in the senior housing segment specifically and in the healthcare industry in general; the ability of the Company’s operators and tenants from its senior housing segment to maintain or increase their occupancy levels and revenues; the ability of the Company’s lessees and mortgagors to maintain the financial strength and liquidity necessary to satisfy their respective obligations to the Company and other third parties; the bankruptcy, insolvency or financial deterioration of the Company’s operators, lessees, borrowers or other obligors; changes in healthcare laws and regulations, including the impact of future or pending healthcare reform, and other changes in the healthcare industry which affect the operations of the Company’s lessees or obligors, including changes in the federal budget resulting in the reduction or nonpayment of Medicare or Medicaid reimbursement rates; the Company’s ability to recruit and retain key management personnel; costs of compliance with regulations and environmental laws affecting the Company’s properties; changes in tax laws and regulations; changes in the financial position or business strategies of HCR ManorCare; the Company’s ability and willingness to maintain its qualification as a REIT due to economic, market, legal, tax or other considerations; changes in rules governing financial reporting, including new accounting pronouncements; and other risks described from time to time in the Company’s Securities and Exchange Commission filings. The Company assumes no, and hereby disclaims any, obligation to update any of the foregoing or any other forward-looking statements as a result of new information or new or future developments, except as otherwise required by law.

Company Information(1)

Board of Directors
James F. Flaherty III	Michael D. McKee
Chairman and Chief Executive Officer	Chief Executive Officer
HCP, Inc.	Bentall Kennedy U.S., L.P.
Christine N. Garvey	Peter L. Rhein
Former Global Head of Corporate	Partner, Sarlot & Rhein
Real Estate Services, Deutsche Bank AG
David B. Henry	Kenneth B. Roath
Vice Chairman, President and Chief	Chairman Emeritus, HCP, Inc.
Executive Officer, Kimco Realty Corporation
Lauralee E. Martin	Joseph P. Sullivan
Chief Operating and Financial Officer	Chairman of the Board of Advisors
Jones Lang LaSalle Incorporated	RAND Health
Senior Management
James F. Flaherty III	Thomas M. Klaritch
Chairman and	Executive Vice President
Chief Executive Officer	Medical Office Properties
Jonathan M. Bergschneider	James W. Mercer
Executive Vice President	Executive Vice President, General Counsel
Life Science Estates	and Corporate Secretary
Paul F. Gallagher	Timothy M. Schoen
Executive Vice President and	Executive Vice President and
Chief Investment Officer	Chief Financial Officer
Edward J. Henning	Susan M. Tate
Executive Vice President	Executive Vice President
	Post-Acute and Hospitals
Thomas D. Kirby
Executive Vice President	Kendall K. Young
Acquisitions and Valuations	Executive Vice President
	Senior Housing
Other Information
Corporate Headquarters	San Francisco Office
3760 Kilroy Airport Way, Suite 300	400 Oyster Point Boulevard, Suite 409
Long Beach, CA 90806-2473	South San Francisco, CA 94080
(562) 733-5100
Nashville Office
3000 Meridian Boulevard, Suite 200
Franklin, TN 37067

The information in this supplemental information package should be read in conjunction with the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other information filed with the Securities and Exchange Commission (“SEC”). The Reporting Definitions and Reconciliations of Non-GAAP Measures are an integral part of the information presented herein.

On the Company’s internet website, www.hcpi.com, you can access, free of charge, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. The information contained on its website is not incorporated by reference into, and should not be considered a part of, this supplemental information package. In addition, the SEC maintains an internet website that contains reports, proxy and information statements, and other information regarding issuers, including HCP, that file electronically with the SEC at www.sec.gov.

For more information, contact Timothy M. Schoen, Executive Vice President - Chief Financial Officer at (562) 733-5309.

(1)As of February 10, 2012.

1

Summary

Dollars in thousands, except per share data

	Three Months Ended December 31,				Year Ended December 31,
	2011		2010		2011		2010
Revenues	$	461,604	$	340,966	$	1,725,386	$	1,253,454
NOI	391,422		229,555		1,403,277		878,423
Adjusted EBITDA	386,599		283,495		1,473,258		1,024,530
FFO applicable to common shares	150,578		202,611		877,907		690,637
FFO as adjusted applicable to common shares	275,578		206,950		1,044,903		683,533
FAD applicable to common shares	202,890		171,292		830,651		578,452
Net income applicable to common shares	61,996		136,202		515,302		307,498
Diluted FFO per common share	$	0.37	$	0.62	$	2.19	$	2.25
Diluted FFO as adjusted per common share	0.67		0.64		2.69		2.23
Diluted FAD per common share	0.50		0.53		2.14		1.89
Diluted EPS	0.15		0.42		1.29		1.00
FFO as adjusted payout ratio	72%		73%		71%		83%
Financial leverage	41%		33%
Adjusted fixed charge coverage	3.4x		3.3x		3.1x		2.9x
	December 31,		December 31,
Total properties:	2011		2010
Senior housing	314		251
Post-acute/skilled nursing	313		45
Life science	108		102
Medical office	254		253
Hospital	21		21
Total	1,010		672

Portfolio Income from Assets Under Management(1)	Assets Under Management:  $18.7 billion(2)

(1)Represents adjusted NOI from real estate owned by HCP, interest income from debt investments and HCP’s pro rata share of adjusted NOI from real estate owned by the Company’s Investment Management Platform, excluding assets under development and land held for development, for the year ended December 31, 2011.

(2)Represents the historical cost of real estate owned by HCP, the carrying amount of debt investments and 100% of the cost of real estate owned by the Company’s Investment Management Platform, excluding assets held for sale and under development and land held for development, at December 31, 2011.

See Reporting Definitions and Reconciliations of Non-GAAP Measures
	2

Funds From Operations

Dollars and shares in thousands, except per share data

	Three Months Ended December 31,						Year Ended December 31,
	2011			2010			2011			2010(1)
Net income applicable to common shares	$	61,996		$	136,202		$	515,302		$	307,498
Depreciation and amortization of real estate, in-place lease and other intangibles:
Continuing operations	87,362			77,820			356,834			311,218
Discontinued operations	5			237			561			2,229
DFL depreciation	2,961			—			8,840			—
Gain on sales of real estate	(3,107		)	(15,873		)	(3,107		)	(19,925		)
Gain upon consolidation of joint venture	—			—			(7,769		)	—
Impairments of investments in joint ventures	—			—			—			71,693
Equity income from unconsolidated joint ventures	(13,952		)	(692		)	(46,750		)	(4,770		)
FFO from unconsolidated joint ventures	16,479			5,579			56,887			25,288
Noncontrolling interests’ and participating securities’ share in earnings	3,509			4,042			18,062			15,767
Noncontrolling interests’ and participating securities’ share in FFO	(4,675		)	(4,704		)	(20,953		)	(18,361		)
FFO applicable to common shares	$	150,578		$	202,611		$	877,907		$	690,637
Distributions on dilutive convertible units	—			2,987			6,916			11,847
Diluted FFO applicable to common shares	$	150,578		$	205,598		$	884,823		$	702,484
Weighted average shares used for diluted FFO per share	409,730			331,960			403,864			312,797
Diluted FFO per common share	$	0.37		$	0.62		$	2.19		$	2.25
Dividends declared per common share	$	0.48		$	0.465		$	1.92		$	1.86
FFO payout ratio	129.7%			75.0%			87.7%			82.7%
Impact of adjustments to FFO:
Litigation settlement charge(2)	$	125,000		$	—		$	125,000		$	—
Other impairments (recoveries)(3)	—			—			15,400			(11,900		)
Merger-related items(4)	—			4,339			26,596			4,339
	$	125,000		$	4,339		$	166,996		$	(7,561	)
FFO as adjusted applicable to common shares	$	275,578		$	206,950		$	1,044,903		$	683,076
Distributions on dilutive convertible units and other	2,858			2,970			11,646			12,089
Diluted FFO as adjusted applicable to common shares	$	278,436		$	209,920		$	1,056,549		$	695,165
Weighted average shares used for diluted FFO as adjusted per share(5)	415,624			325,960			393,237			311,285
Diluted FFO as adjusted per common share(5)	$	0.67		$	0.64		$	2.69		$	2.23
FFO as adjusted payout ratio	71.5%			72.7%			71.5%			83.4%

(1)Certain amounts for prior periods have been restated to conform to NAREIT’s updated reporting guidance on FFO. For additional details regarding “FFO”, see reporting definitions.

(2)This charge during the year ended December 31, 2011 relates to the settlement with Ventas, Inc.

(3)The impairment charge during the year ended December 31, 2011 relates to the Company’s senior secured loan to Cirrus Health. Recoveries for the year ended December 31, 2010 of $11.9 million relate to portions of previous impairment charges related to investments in three direct financing leases (non-depreciable due to lessee purchase option) and a participation interest in a senior construction loan related to Erickson Retirement Communities.

(4)Merger-related items for the year ended December 31, 2011 are attributable to the HCR ManorCare Acquisition (incurred from January 1st through April 6th 2011), which include the following: (i) $26.8 million of direct transaction costs, (ii) $23.9 million of interest expense associated with the $2.4 billion senior unsecured notes issued on January 24, 2011, proceeds from which were obtained to prefund the HCR ManorCare Acquisition, partially offset by (iii) $24.1 million of income related to gains upon the reinvestment of the Company’s debt investment in HCR ManorCare and other miscellaneous items. Merger-related items for 2010 primarily include professional fees associated with the HCR ManorCare Acquisition.

(5)The weighted average shares used to calculate diluted FFO as adjusted eliminate the impact of the Company’s December 2010 46 million shares of common stock offering and 30 million shares from its March 2011 common stock offering (excludes 4.5 million shares sold to the underwriters upon exercise of their option to purchase additional shares), which issuances increased the weighted average shares by 12.9 million and 1.5 million for the years ended December 31, 2011 and 2010, respectively. Proceeds from these offerings were used to fund a portion of the cash consideration for the HCR ManorCare Acquisition.

See Reporting Definitions and Reconciliations of Non-GAAP Measures
	3

Funds Available for Distribution

Dollars and shares in thousands, except per share data

	Three Months Ended December 31,						Year Ended December 31,
	2011			2010			2011			2010
FFO as adjusted applicable to common shares	$	275,578		$	206,950		$	1,044,903		$	683,076
Amortization of above and below market lease intangibles, net	(1,239		)	(1,041		)	(4,510		)	(6,378		)
Amortization of deferred compensation (stock-based)	4,748			3,618			20,034			14,924
Amortization of debt premiums, discounts and issuance costs, net(1)	3,651			1,840			13,716			9,078
Straight-line rents	(12,237		)	(14,374		)	(59,173		)	(47,243		)
DFL accretion(2)	(25,499		)	(2,300		)	(74,007		)	(10,641		)
DFL depreciation	(2,961		)	—			(8,840		)	—
Deferred revenues – tenant improvement related	(237		)	(929		)	(2,371		)	(3,714		)
Deferred revenues – additional rents (SAB 104)	(798		)	(810		)	52			(270		)
Leasing costs and tenant and capital improvements(3)	(21,131		)	(20,853		)	(52,903		)	(54,237		)
Joint venture and other FAD adjustments(2)	(16,985		)	(809		)	(46,250		)	(6,143		)
FAD applicable to common shares	$	202,890		$	171,292		$	830,651		$	578,452
Distributions on convertible units	1,758			1,714			6,916			6,676
Diluted FAD applicable to common shares	$	204,648		$	173,006		$	837,567		$	585,128
Weighted average shares used for diluted FAD per share	413,338			323,644			390,944			308,953
Diluted FAD per common share	$	0.50		$	0.53		$	2.14		$	1.89

(1)Excludes $11.3 million related to the write-off of unamortized loan fees for the Company’s expired bridge loan commitment and $0.8 million related to the amortization of deferred issuance costs of the senior notes, which costs are included in merger-related items for the year ended December 31, 2011.

(2)For the quarter and year ended December 31, 2011, DFL accretion reflects an elimination of $14.5 million and $42.2 million respectively. The Company’s ownership interest in HCR ManorCare OpCo is accounted for using the equity method, which requires an ongoing elimination of DFL income that is proportional to its ownership in HCR ManorCare OpCo. Further, the Company’s share of earnings from HCR ManorCare OpCo (equity income) increases for the corresponding elimination of related lease expense recognized at the HCR ManorCare OpCo level, which is presented as a non-cash joint venture FAD adjustment.

(3)Excludes $41 million ($2 million in 4Q2010 and $39 million in 3Q2010) of deferred leasing costs related to the buyout of management contracts for 27 Sunrise-managed communities. On November 1, 2010, the Company exercised its rights to terminate management contracts relating to 27 senior housing communities previously operated by Sunrise; the Company’s net investment to acquire these termination rights was $41 million, which consisted of a $50 million payment to Sunrise that was partially offset for certain working capital acquired in conjunction with this transaction.

See Reporting Definitions and Reconciliations of Non-GAAP Measures
	4

Capitalization

Dollars and shares in thousands, except price data

Total Debt
	December 31, 2011		December 31, 2010
Bank line of credit	$	454,000	$	—
Senior unsecured notes	5,416,063		3,318,379
Mortgage debt	1,764,571		1,235,779
Other debt	87,985		92,187
Consolidated debt	7,722,619		4,646,345
HCP’s share of unconsolidated debt(1)	143,196		335,966
Total debt	$	7,865,815	$	4,982,311

Total Market Capitalization
	December 31, 2011
	Shares	Value		Total Value
Common stock	408,629	$	41.43	$	16,929,499
Convertible partnerships (DownREITs)(2)	5,895	41.43		244,230
Preferred stock:
7.25% Series E (Callable at par)	4,000	25.50		102,000
7.10% Series F (Callable at par)	7,820	25.43		198,863
	11,820			300,863
Total market equity				$	17,474,592
Consolidated debt				7,722,619
Total market equity and consolidated debt				$	25,197,211
HCP’s share of unconsolidated debt(1)				143,196
Total market capitalization				$	25,340,407

Common Stock and Equivalents
		Weighted Average Shares		Weighted Average Shares
	Shares	Three Months Ended		Year Ended
	Outstanding	December 31, 2011		December 31, 2011
	December 31, 2011	Diluted EPS	Diluted FFO	Diluted EPS	Diluted FFO
Common stock	408,629	407,907	407,907	398,446	398,446
Common equivalent securities:
Restricted stock and units	1,817	299	299	253	253
Dilutive impact of options	1,524	1,524	1,524	1,519	1,519
Convertible partnership units	5,895	—	—	—	3,646
Total common and equivalents	417,865	409,730	409,730	400,218	403,864

Other Information
Trading Symbol		Stock Exchange Listing
HCP	Common Stock	NYSE
HCP_pe	Series E Preferred Stock
HCP_pf	Series F Preferred Stock

(1)Reflects the Company’s pro rata share of amounts in the Investment Management Platform and HCR ManorCare OpCo.

(2)Convertible partnership (DownREIT) units are exchangeable for an amount of cash approximating the then-current market value of shares of the Company’s common stock at the time of conversion or, at the Company’s election, shares of the Company’s common stock.

See Reporting Definitions and Reconciliations of Non-GAAP Measures
	5

Credit Profile

Financial Leverage and Secured Debt Ratio

Adjusted Fixed Charge Coverage (12 months)

Liquidity(3)

(In billions)

Total Gross Assets

(In billions)

Credit Ratings (Senior Unsecured Debt)

	Pre-CNL(1)  Acquisition	2006	2007	2008	2009	2010	2011
Moody’s	Baa2	Baa3	Baa3	Baa3	Baa3	Baa3	Baa2 (Stable)
Standard & Poor’s	BBB+	BBB	BBB	BBB	BBB	BBB	BBB (Positive)
Fitch	BBB+	BBB	BBB	BBB	BBB	BBB	BBB+ (Stable)

(1)As of and for the six months ended June 30, 2006. The Company completed the mergers with CNL Retirement Properties, Inc. and CNL Retirement Corp (“CNL”) on October 5, 2006, with significant prefunding activities occurring in the quarter ended September 30, 2006; therefore, the Company refers to the period ended June 30, 2006 as “Pre-CNL Acquisition.”

(2)Financial leverage, secured debt ratio, liquidity, and total gross assets are pro forma to exclude the temporary benefit resulting from prefunding the HCR ManorCare acquisition in December 2010.

(3)Represents the availability under the Company’s bank line of credit and cash and cash equivalents (unrestricted cash).

(4)On January 23, 2012, the Company issued $450 million of senior unsecured notes. Pro forma for this issuance, the Company’s liquidity would have been $1.5 billion at December 31, 2011.

See Reporting Definitions and Reconciliations of Non-GAAP Measures
	6

Indebtedness and Ratios

Dollars in thousands

Debt Maturities and Scheduled Principal Repayments (Amortization)
December 31, 2011
			Senior													HCP’s Share of
	Bank Line		Unsecured					Mortgage					Consolidated			Unconsolidated
	of Credit		Notes			Rates(1)		Debt(2)			Rates(1)		Debt			Debt(3)			Rates(1)		Total Debt
2012	$	—	$	250,000		6.67	%	$	66,761		4.91	%	$	316,761		$	9,621		5.31	%	$	326,382
2013	—		550,000			5.81		367,374			6.04		917,374			3,165			7.04		920,539
2014	—		487,000			3.28		183,758			5.74		670,758			738			N/A		671,496
2015	454,000		400,000			6.64		302,102			6.01		1,156,102			11,231			5.82		1,167,333
2016	—		900,000			5.07		285,586			6.92		1,185,586			46,936			6.05		1,232,522
2017	—		750,000			6.04		512,460			6.10		1,262,460			34,780			5.91		1,297,240
2018	—		600,000			6.83		5,747			5.90		605,747			36,921			5.00		642,668
2019	—		—			—		1,184			N/A		1,184			—			—		1,184
2020	—		—			—		1,276			N/A		1,276			—			—		1,276
2021	—		1,200,000			5.53		4,242			5.57		1,204,242			—			—		1,204,242
Thereafter	—		300,000			6.89		47,778			5.18		347,778			—			—		347,778
Subtotal	454,000		5,437,000					1,778,268					7,669,268			143,392					7,812,660
Other debt(4)	—		—					—					87,985			—					87,985
(Discounts) and premiums, net	—		(20,937		)			(13,697		)			(34,634		)	(196		)			(34,830		)
Total debt	$	454,000	$	5,416,063				$	1,764,571				$	7,722,619		$	143,196				$	7,865,815
Weighted average interest rate	2.26%		5.70%					6.12%					5.59%			5.84%					5.60%
Weighted average maturity in years	3.24		6.34					4.37					5.70			4.82					5.68

Ratios			Covenants
	December 31,	December 31,	The following is a summary of the financial covenants under the revolving line of credit facility at December 31, 2011.
	2011	2010
Consolidated Debt/Consolidated Gross Assets	41.0%	31.9%
Financial Leverage (Total Debt/Total Gross Assets)	41.0%	32.8%		Bank Line of Credit
			Financial Covenants(5)	Requirement	Actual Compliance
Consolidated Secured Debt/Consolidated Gross Assets	9.4%	8.5%	Leverage Ratio	No greater than 60%	42%
Secured Debt Ratio (Total Secured Debt/Total Gross Assets)	10.0%	10.4%	Secured Debt Ratio	No greater than 30%	11%
			Unsecured Leverage Ratio	No greater than 60%	40%
Fixed and variable rate ratios(6):			Fixed Charge Coverage Ratio (12 months)	No less than 1.50x	2.98x
Fixed rate Total Debt	93.1%	93.8%
Variable rate Total Debt	6.9%	6.2%
	100.0%	100.0%

(1)Senior unsecured notes and mortgage debt weighted-average effective rates relate to maturing amounts.

(2)Mortgage debt attributable to non-controlling interests at December 31, 2011was $67 million.

(3)Includes pro-rata share of mortgage and other debt in the Company’s Investment Management Platform and HCR ManorCare OpCo. At December 31, 2011, 100% of the Company’s Investment Management Platform’s mortgage debt accrues interest at fixed rates. HCR ManorCare OpCo’s debt accrues interest at LIBOR (subject to a floor of 150bps) plus 350bps.

(4)Represents non-interest bearing life care bonds and occupancy fee deposits at certain of the Company’s senior housing facilities that have no scheduled maturities.

(5)Financial covenants for the revolving line of credit facility are calculated based on the definitions contained within the agreement and may be different than similar terms in the Company’s Consolidated Financial Statements as provided in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Compliance with certain of these financial covenants requires the inclusion of the Company’s consolidated amounts and its proportionate share of unconsolidated investees.

(6)$88 million of variable-rate mortgages are presented as fixed-rate debt as the interest payments under such debt have been swapped (pay fixed and receive float).

See Reporting Definitions and Reconciliations of Non-GAAP Measures

7

Investments and Dispositions

Dollars in thousands
Investments
	December 31, 2011
Description	Three Months Ended		Year Ended
HCR ManorCare real estate acquisition(1)	$	—	$	6,016,962
HCR ManorCare OpCo investment(1)	—		95,000
HCP Ventures II acquisition(2)	—		546,979
Acquisitions of other real estate	—		173,199
Total fundings for development, tenant and capital improvements(3)	39,831		127,039
Construction loan commitment fundings	6,601		10,256
Total investments	$	46,432	$	6,969,435

Dispositions
Description		Capacity	Property Count	Segment	Payoff/ Settlement Value and Sales Price, Net of Costs
Location	Date
Three Months Ended December 31, 2011:
Various, KS	November 22, 2011	169 Units	2	Senior housing	$	17,570
Various, GA	December 27, 2011	40 Units	1	Senior housing	1,613
Total					$	19,183
Year Ended December 31, 2011:
Dispositions of real estate properties	Various		3	Senior housing	$	19,183
Genesis	April 1, 2011			Post-acute/skilled	330,396
HCR ManorCare(4)	April 7, 2011			Post-acute/skilled	1,630,720
Total					$	1,980,299

(1)On April 7, 2011, the Company acquired the real estate assets of privately-owned HCR ManorCare, Inc. for $6.1 billion. After reducing the purchase price by $88 million, which represents the difference between the fair value and the par value of the HCR ManorCare debt investments (at closing) that were settled as part of this acquisition, the adjusted purchase price is $6.0 billion. The adjusted purchase price of the HCR ManorCare real estate acquisition is comprised of the following: (i) $4.0 billion of cash consideration; and (ii) $2.0 billion representing the fair value of the HCR ManorCare debt investments. In conjunction with the acquisition of the real estate assets of HCR ManorCare, the Company exercised its option to purchase an equity interest in the operations of HCR ManorCare for $95 million that represented a 9.9% equity interest at closing.

(2)Represents 65% of the acquired investments from HCP Ventures II. On January 14, 2011, the Company acquired its partner’s 65% interest in a joint venture that owns 25 senior housing facilities with 5,621 units, becoming the sole owner of the portfolio. At closing, the Company paid approximately $136 million for the interest and assumed its partner’s share of $650 million (fair value of $635 million) of Fannie Mae secured debt with a weighted average fixed-rate of 5.66% and weighted average term to maturity of 5.3 years. At closing, the Company valued the HCP Ventures II investment at approximately $842 million.

(3)The three months ended December 31, 2011, includes the following: (i) $17.8 million of development, (ii) $10.3 million of first generation tenant and capital improvements, and (iii) $11.7 million of second generation tenant and capital improvements (excludes $9.4 million of leasing costs). The year ended December 31, 2011, includes the following: (i) $60.4 million of development, (ii) $32.6 million of first generation tenant and capital improvements, and (iii) $34.0 million of second generation tenant and capital improvements (excludes $18.9 million of leasing costs). Investments for development include capitalized interest for the quarter and year ended December 31, 2011 of $7.0 million and $26.4 million, respectively.

(4)Settlement value of the debt investments in HCR ManorCare presented excludes the $360 million participation in the first mortgage debt that the Company purchased on January 31, 2011 as this purchase was for the sole purpose of prefunding the HCR ManorCare Acquisition.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

8

Development

As of December 31, 2011, dollars and square feet in thousands
Development Projects in Process
			Estimated/	Estimated
			Actual	Rentable			Estimated
			Completion	Square	Investment		Total
Name of Project	Location	Segment	Date	Feet	to Date(1)(3)		Investment
Development
2019 Stierlin Ct.	Mountain View, CA	Life science	1Q 2013	70	$	1,290	$	25,487
Redevelopment
Modular Labs IV	So. San Francisco, CA	Life science	4Q 2010	97	56,178		57,069
Soledad(4)	San Diego, CA	Life science	3Q 2011	28	12,693		14,932
1030 Massachusetts Avenue	Cambridge, MA	Life science	2Q 2012	75	28,236		39,992
Durham Research Lab	Durham, NC	Life science	2Q 2012	53	10,073		12,573
Knoxville	Knoxville, TN	Medical office	4Q 2011	38	7,558		8,740
Westpark Plaza	Plano, TX	Medical office	1Q 2012	70	12,102		17,159
Folsom	Sacramento, CA	Medical office	4Q 2012	92	30,320		39,251
Innovation Drive	San Diego, CA	Medical office	3Q 2012	84	24,791		33,689
Fresno(5)	Fresno, CA	Hospital	4Q 2012	N/A	5,733		20,554
	Total				$	188,974	$	269,446

Land Held for Development
				Estimated
			Gross	Rentable
			Site	Square
	Location	Segment	Acreage	Feet
	So. San Francisco, CA	Life science	50	1,666
	Carlsbad, CA	Life science	41	690
	Poway, CA	Life science	72	1,204
	Torrey Pines, CA	Life science	6	93
			169	3,653
	Investment-to-date(2)(3)			$	374,438

Projects Placed in Service
			Date	Rentable
			Placed in	Square			Percentage
Name of Project	Location	Segment	Service	Feet	Investment(6)		Leased
500/600 Saginaw	Redwood City, CA	Life science	March 2011	88	$	43,030	—

(1)Investment-to-date of $189 million includes the following: (i) $66 million in development costs and construction in progress, (ii) $78 million of buildings and (iii) $45 million of land.

(2)Investment-to-date of $374 million includes the following: (i) $286 million in land and (ii) $88 million in development costs and construction in progress.

(3)Development costs and construction in progress of $191 million presented on the Company’s consolidated balance sheet at December 31, 2011, includes the following: (i) $66 million of costs for development projects in process; (ii) $88 million of costs for land held for development; and (iii) $37 million for tenant and other facility related improvement projects in process.

(4)Represents approximately half of the Soledad project remaining in redevelopment. The balance of the project was placed in service during the quarter ended December 31, 2010.

(5)Represents approximately 25% of the Fresno hospital placed in redevelopment in March 2011. The balance of the hospital remains in operations.

(6)Represents the investment as of the date the respective property was placed in service.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

9

Owned Portfolio Summary

As of and for the year ended December 31, 2011, dollars and square feet in thousands
Portfolio Summary by Investment Product
Leased	Property					Age			Occupancy	EBITDAR(1)			EBITDARM(1)
Properties	Count	Investment		NOI		(Years)	Capacity		%	Amount		CFC	Amount		CFC
Senior housing	293	$	5,146,325	$	480,826	15	31,139	Units	85.3	$	402,394	1.18 x	$	478,463	1.40 x
Post-acute/skilled	313	5,545,472		398,218		32	41,803	Beds	87.2	67,663		1.84 x	88,101		2.40 x
Life science	104	3,259,303		235,355		17	6,798	Sq. Ft.	89.9	N/A		N/A	N/A		N/A
Medical office	188	2,297,218		192,796		20	13,111	Sq. Ft.	91.5	N/A		N/A	N/A		N/A
Hospital	17	648,386		78,798		25	2,379	Beds	52.2	335,932		4.25 x	370,837		4.69 x
	915	$	16,896,704	$	1,385,993	22
Operating Properties (RIDEA)	Property Count	Investment		NOI		Age (Years)	Capacity		Occupancy %
Senior housing(2)	21	$	749,850	$	17,284	21	5,000	Units	89.5
Debt Investments		Investment		Interest Income
Senior housing		$	10,256	$	178
Post-acute/skilled(3)		9,746		98,450
Hospital(4)		90,250		1,236
		$	110,252	$	99,864
Total	936	$	17,756,806	$	1,503,141

Portfolio NOI, Adjusted NOI and Interest Income
	Three Months Ended December 31, 2011
	Rental and										Adjusted NOI
	RIDEA		Operating				Adjusted		Interest		and Interest
Segment	Revenues		Expenses		NOI(5)		NOI		Income(6)		Income
Senior housing(2)	$	153,263	$	23,174	$	130,089	$	116,732	$	129	$	116,861
Post-acute/skilled	133,434		274		133,160		113,164		283		113,447
Life science	73,106		14,137		58,969		52,706		—		52,706
Medical office	79,658		30,550		49,108		47,848		—		47,848
Hospital	21,010		914		20,096		19,540		253		19,793
	$	460,471	$	69,049	$	391,422	$	349,990	$	665	$	350,655
	Year Ended December 31, 2011
	Rental and										Adjusted NOI
	RIDEA		Operating				Adjusted		Interest		and Interest
Segment	Revenues		Expenses		NOI(5)		NOI		Income(6)		Income
Senior housing(2)	$	532,656	$	34,546	$	498,110	$	443,105	$	178	$	443,283
Post-acute/skilled	398,811		593		398,218		341,195		98,450		439,645
Life science	288,151		52,796		235,355		212,251		—		212,251
Medical office	320,703		127,907		192,796		186,761		—		186,761
Hospital	83,128		4,330		78,798		76,402		1,236		77,638
	$	1,623,449	$	220,172	$	1,403,277	$	1,259,714	$	99,864	$	1,359,578

(1)    EBITDAR, EBITDARM and their respective CFC are not presented for the disaggregated HCR ManorCare senior housing and post-acute/skilled nursing portfolios as the combined portfolio is cross-collateralized under a single master lease. See HCR ManorCare Leased Portfolio Summary on page 17 of this report.

(2)    Beginning September 1, 2011, Brookdale Senior Living manages 21 assets on behalf of the Company under a RIDEA structure. For the three months ended December 31, 2011, revenues and operating expenses were $35.2 million and $22.4 million, respectively. For the year ended December 31, 2011, revenues and operating expenses were $47.1 million and $29.8 million, respectively.

(3)    On April 7, 2011, the Company completed the acquisition of HCR ManorCare’s real estate assets. At closing of the HCR ManorCare Acquisition, the Company’s debt investments in HCR ManorCare were extinguished. For additional information regarding the HCR ManorCare Acquisition see Note 3 to the Consolidated Financial Statements for the year ended December 31, 2011 included in the Company’s Annual Report on Form 10-K filed with the SEC. Includes $43 million of interest income related to debt investments in Genesis HealthCare that were prepaid on April 1, 2011. For additional information regarding the Genesis HealthCare debt investments see Note 7 to the Consolidated Financial Statements for the year ended December 31, 2011 included in the Company’s Annual Report on Form 10-K filed with the SEC.

(4)    Includes a senior secured loan to Cirrus Health (“Cirrus”) that was placed on non-accrual status effective January 1, 2011 with a carrying value of $76 million at December 31, 2011. For additional information regarding the senior secured loan to Cirrus see Note 7 to the Consolidated Financial Statements for the year ended December 31, 2011 included in the Company’s Annual Report on Form 10-K filed with the SEC.

(5)    NOI attributable to non-controlling interests for the three months and year ended December 31, 2011 was $4.2 million and $5.7 million, respectively.

(6)    Includes loan accretion for the three months and year ended December 31, 2011 of $0.3 million and $19.0 million, respectively.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

10

Owned Portfolio Concentrations

As of and for the year ended December 31, 2011, dollars in thousands

Geographic Diversification of Properties

	Total	Senior		Post-Acute/		Life		Medical								% of
Investment by State	Properties	Housing		Skilled		Science		Office			Hospital		Total			Total
CA	149	$	623,514	$	265,166	$	3,139,734	$		213,244	$	128,545	$		4,370,203	25
TX	97	707,001		102,495		—		694,248			227,242		1,730,986			10
FL	95	832,700		530,648		—		154,446			62,450		1,580,244			9
PA	54	258,782		1,178,327		—		—			—		1,437,109			8
IL	51	503,719		683,850		—		13,481			—		1,201,050			7
OH	72	212,831		667,428		—		9,219			—		889,478			5
MI	38	175,636		564,005		—		—			—		739,641			4
MD	34	297,656		225,523		—		29,524			—		552,703			3
VA	29	319,393		172,809		—		41,758			—		533,960			3
NJ	21	374,955		97,119		—		—			—		472,074			3
Other	296	1,589,988		1,058,102		119,569		1,141,298			230,149		4,139,106			23
Total	936	$	5,896,175	$	5,545,472	$	3,259,303	$	2,297,218		$	648,386	$	17,646,554		100
	Total	Senior		Post-Acute/		Life		Medical								% of
NOI by State	Properties	Housing		Skilled		Science		Office			Hospital		Total			Total
CA	149	$	62,787	$	19,037	$	222,429	$		13,236	$	16,691	$		334,180	24
TX	97	58,266		6,305		—		52,718			25,163		142,452			10
FL	95	69,567		36,249		—		13,904			7,792		127,512			9
PA	54	17,978		82,320		—		—			—		100,298			7
IL	51	39,333		46,120		—		1,279			—		86,732			6
OH	72	16,317		50,451		—		552			—		67,320			5
MI	38	15,092		37,464		—		—			—		52,556			4
MD	34	23,745		15,600		—		2,936			—		42,281			3
VA	29	23,759		14,368		—		3,540			—		41,667			3
CO	26	16,676		5,985		—		15,263			1,397		39,321			3
Other	291	154,590		84,319		12,926		89,368			27,755		368,958			26
Total	936	$	498,110	$	398,218	$	235,355	$		192,796	$	78,798	$		1,403,277	100

Operator/Tenant Diversification

	Primary	Annualized Revenues(1)
Company	Segment	Amount			%
HCR ManorCare	Post-acute/skilled	$		472,500	32
Brookdale Senior Living	Senior housing	141,165			10
Emeritus Corporation	Senior housing	100,939			7
Sunrise Senior Living	Senior housing	84,793			6
HCA	Hospital	46,995			3
Amgen	Life science	41,316			3
Genentech	Life science	37,528			3
Kindred	Post-acute/skilled	16,732			1
Tenet Healthcare	Hospital	16,018			1
Capital Senior Living	Senior housing	15,847			1
Other		491,381			33
		$	1,465,214		100

(1)   The most recent monthly base rent (including additional rent floors), cash income from direct financing leases and/or interest income annualized for 12 months. Annualized revenues for operating properties under a RIDEA structure are based on the most recent month’s NOI annualized for 12 months. For additional details regarding “annualized revenues,” see reporting definitions.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

11

Owned Same Property Portfolio

As of December 31, 2011, dollars and square feet in thousands

Three-Month SPP
			Senior		Post-Acute/		Life		Medical
	Total		Housing		Skilled		Science		Office		Hospital
Property count	563		222		45		96		184		16
Investment	$	10,364,408	$	4,208,505	$	245,304	$	3,084,175	$	2,217,783	$	608,641
Percent of property portfolio (by investment)	58.7%		71.4%		4.4%		94.6%		96.5%		93.9%
Capacity			25,554 Units		5,316 Beds		6,406 Sq. Ft.		12,817 Sq. Ft		2,379 Beds

Year-Over-Year Three-Month SPP

Occupancy:
December 31, 2011			85.5%			84.9%			92.8%		91.3%		48.4%
December 31, 2010			86.2%			85.7%			91.3%		90.9%		52.0%
% change			(0.7%		)	(0.8%		)	1.5%		0.4%		(3.6%		)
NOI % change	1.0%		1.3%			(0.0%		)	0.4%		0.9%		2.5%
Adjusted NOI:
December 31, 2011	$	216,471	$	87,710		$	9,214		$	52,508	$	48,085	$	18,954
December 31, 2010	$	211,740	$	85,338		$	9,078		$	51,957	$	46,972	$	18,395
Adjusted NOI % change	2.2%		2.8%			1.5%			1.1%		2.4%		3.0%

Sequential Three-Month SPP

Occupancy:
December 31, 2011			85.5%			84.9%			92.8%			91.3%		48.4%
September 30, 2011			85.2%			85.5%			92.9%			90.7%		53.1%
% change			0.3%			(0.6%		)	(0.1%		)	0.6%		(4.7%		)
NOI % change	1.5%		0.8%			(1.4%		)	1.9%			2.8%		2.5%
Adjusted NOI:
December 31, 2011	$	216,471	$	87,710		$	9,214		$	52,508		$	48,085	$	18,954
September 30, 2011	$	212,657	$	85,692		$	9,314		$	52,501		$	46,670	$	18,480
Adjusted NOI % change	1.8%		2.4%			(1.1%		)	0.0%			3.0%		2.6%
Year-Over-Year SPP(1)
			Senior			Post Acute/			Life			Medical
	Total		Housing			Skilled			Science			Office		Hospital
Property count	554		216			45			95			182		16
Investment	$	10,189,200	$	4,082,069		$	245,304		$	3,054,991		$	2,198,195	$	608,641
Percentage of property portfolio (by investment)	57.7%		69.2%			4.4%			93.7%			95.7%		93.9%
Capacity			24,807 Units			5,316 Beds			6,320 Sq. Ft.			12,713 Sq. Ft.		2,379 Beds
Year-Over-Year SPP
Occupancy:
December 31, 2011			85.8%			84.9%			92.7%			91.3%		48.4%
December 31, 2010			86.2%			85.7%			91.2%			90.8%		52.0%
% change			(0.4%		)	(0.8%		)	1.5%			0.5%		(3.6%		)
NOI % change	4.4%		8.8%			2.0%			0.7%			2.6%		0.6%
Adjusted NOI:
December 31, 2011	$	837,556	$	332,719		$	36,849		$	208,603		$	185,415	$	73,970
December 31, 2010	$	805,568	$	312,156		$	35,925		$	206,381		$	180,378	$	70,728
Adjusted NOI % change	4.0%		6.6%			2.6%			1.1%			2.8%		4.6%

(1)   Full Year SPP excludes nine properties reported in three-month SPP as those properties were not in operations for the duration of the year-over-year comparison periods presented.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

12

Owned Portfolio Lease Expirations and Debt Investment Maturities

At December 31, 2011, dollars and square feet in thousands

			Expiration Year(1)
Segment	Total		2012(2)		2013		2014		2015		2016		2017		2018		2019		2020		2021		Thereafter
Lease Expirations
Senior housing(3):
Properties	293		—		2		5		1		17		12		49		12		33		37		125
Annualized revenues	$	413,294	$	—	$	11,567	$	4,970	$	204	$	24,746	$	19,743	$	95,422	$	15,464	$	50,889	$	17,235	$	173,054
Post-acute/skilled:
Properties	313		—		—		9		1		6		9		3		12		4		—		269
Annualized revenues	$	452,449	$	—	$	—	$	7,062	$	439	$	5,507	$	8,480	$	1,696	$	9,924	$	2,996	$	—	$	416,345
Life science:
Square feet	6,113		185		418		275		816		333		867		554		68		881		557		1,159
Annualized revenues	$	221,538	$	3,660	$	10,595	$	8,482	$	25,811	$	9,467	$	27,996	$	25,925	$	2,844	$	40,616	$	30,747	$	35,395
Medical office:
Square feet	12,001		1,871		1,762		1,623		1,325		1,134		697		967		676		843		358		745
Annualized revenues	$	256,328	$	41,461	$	33,507	$	36,448	$	29,898	$	23,027	$	15,051	$	19,328	$	13,788	$	19,365	$	9,343	$	15,112
Hospital:
Properties	17		—		1		3		—		—		2		—		4		—		1		6
Annualized revenues	$	67,226	$	—	$	2,553	$	16,018	$	—	$	—	$	4,706	$	—	$	6,454	$	—	$	1,650	$	35,845
Total annualized revenues	$	1,410,835	$	45,121	$	58,222	$	72,980	$	56,352	$	62,747	$	75,976	$	142,371	$	48,474	$	113,866	$	58,975	$	675,751
% of Total	100		3		4		5		4		4		5		10		3		8		4		50
Debt Investment Maturities(4)
Senior housing:
Annualized revenues	$	679	$	—	$	—	$	—	$	—	$	650	$	29	$	—	$	—	$	—	$	—	$	—
Post-acute/skilled:
Annualized revenues	$	1,145	$	—	$	977	$	168	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Total annualized revenues	$	1,824	$	—	$	977	$	168	$	—	$	650	$	29	$	—	$	—	$	—	$	—	$	—

(1)The most recent monthly base rent (including additional rent floors), cash income from direct financing leases and/or interest income annualized for 12 months. For additional details regarding “annualized revenues,” see reporting definitions.

(2)Includes month-to-month and holdover leases.

(3)Excludes 21 facilities with annualized NOI of $52.6 million operated under a RIDEA structure by Brookdale Senior Living.

(4)Effective January 1, 2011, a senior secured loan to Cirrus was placed on non-accrual status. During the three months and year ended December 31, 2011, no revenues were recognized for this loan; consequently, no annualized revenue amounts for this loan are presented. For additional information regarding the senior secured loan to Cirrus see Note 7 to the Consolidated Financial Statements for the year ended December 31, 2011 included in the Company’s Annual Report on Form 10-K filed with the SEC. Additionally, zero coupon loans are excluded from debt investment maturities.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

13

Owned Senior Housing Portfolio

As of and for the year ended December 31, 2011, dollars in thousands

Investments

Operating	Property					Average		Occupancy	EBITDAR			EBITDARM
Leases	Count	Investment		NOI		Age (Years)	Units	%	Amount		CFC	Amount		CFC
Assisted living	162	$	2,470,901	$	229,771	13	14,618	85.4	$	226,189	1.18 x	$	269,330	1.41 x
Independent living	26		625,500		91,605	20	4,661	84.7		58,935	1.08 x		67,339	1.23 x
CCRCs	12		607,427		55,747	22	3,766	88.9		66,846	1.21 x		78,889	1.42 x
	200	$	3,703,828	$	377,123	15	23,045	85.8	$	351,970	1.17 x	$	415,558	1.38 x
Direct Financing	Property					Average		Occupancy		EBITDAR(1)			EBITDARM(1)
Leases	Count	Investment		NOI		Age (Years)	Units	%	Amount		CFC	Amount		CFC
Assisted living	27	$	618,558	$	52,819	15	3,141	86.0	$	50,424	1.24 x	$	62,905	1.54 x
HCR ManorCare(1)	66		823,939		50,884	16	4,953	82.4		N/A	N/A		N/A	N/A
	93	$	1,442,497	$	103,703	15	8,094	83.8
Leased Properties	293	$	5,146,325	$	480,826	15	31,139	85.3	$	402,394	1.18 x	$	478,463	1.40 x
Operating Properties (RIDEA)	Property Count	Investment		NOI		Average Age (Years)	Units	Occupancy %
Assisted living	3	$	24,058	$	678	21	215	94.8
Independent living	18		725,792		16,606	21	4,785	89.2
	21		749,850		17,284	21	5,000	89.5
Debt Investments		Investment		Interest Income
Assisted living(2)		$	10,256	$	178
Total	314	$	5,906,431	$	498,288		36,139	85.9

Operator Concentration(3)
							NOI and
	Properties			Investment			Interest Income			Occupancy	EBITDAR	EBITDARM
Operator	Count	%Pooled		Amount	%		Amount	%	Units	%	CFC(1)	CFC(1)
Brookdale Senior Living(4)	59	61	$	1,679,276	29	$	144,832	29	11,589	87.4	1.34 x	1.56 x
Sunrise Senior Living(5)(6)	48	98		1,317,908	22		97,479	20	5,568	87.4	1.18 x	1.45 x
Emeritus Corporation(5)	69	96		1,135,805	19		126,922	25	7,741	86.2	1.11 x	1.30 x
HCR ManorCare(1)	66	100		823,939	14		50,884	10	4,953	82.4	N/A	N/A
Harbor Retirement Associates	14	100		210,984	4		15,561	3	1,346	85.8	1.16 x	1.46 x
Aegis Senior Living	10	80		182,152	3		15,725	3	701	86.6	1.02 x	1.19 x
Other(4)	48	94		556,367	9		46,885	10	4,241	85.9	1.12 x	1.33 x
	314	90	$	5,906,431	100	$	498,288	100	36,139	85.9	1.18 x	1.40 x

(1)EBITDAR, EBITDARM and their respective CFC are not presented for the disaggregated HCR ManorCare senior housing and post-acute/skilled nursing portfolios as the combined portfolio is cross-collateralized under a single master lease. See HCR ManorCare Leased Portfolio Summary on page 17 of this report.

(2)During the quarter and year ended December 31, 2011, the Company executed loan commitments to fund up to $35 million and $101 million, respectively, of construction financing; for the year ended December 31, 2011, the Company funded $10.3 million related to these commitments. For each of these facilities, the Company holds a one-time purchase option upon the earlier of stabilized occupancy or the fourth anniversary of the loan closing.

(3)Property count, units, occupancy and CFCs are presented for leased and operating properties, if applicable, and exclude debt investments.

(4)Includes 35 assets formerly operated by Horizon Bay Retirement Living transitioned to Brookdale in September 2011. Occupancy for the 35 assets and CFC for 14 of the 35 assets subject to an operating lease will be reported in “other” until the requisite periods have elapsed to allow us to report such measures completely under the new operator. CFC for the remaining 21 assets operated under a RIDEA structure is excluded as CFC is not applicable.

(5)On November 1, 2010, the Company transitioned 27 assets formerly operated by Sunrise Senior Living to Emeritus Corporation. For these transitioned assets, occupancy and CFC are disclosed under “other” until the requisite periods have elapsed to allow us to report such measures completely under the new operator.

(6)Sunrise Senior Living’s percentage pooled consists of 47 assets under 6 separate pools.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

14

Owned Senior Housing Portfolio

Dollars in thousands

Portfolio Trends

	Same Property Leased Portfolio															Total Property Portfolio
										As of and for the
	As of and for the Quarter Ended									YTD Period Ended						As of and for the Twelve Months Ended
	12/31/11			09/30/11			12/31/10			12/31/11			12/31/10			12/31/11(1)(2)		09/30/11(1)(2)(3)		12/31/10(3)
Property count	222			222			222			216			216			314		317		226
Investment	$	4,208,505		$	4,202,917		$	4,190,079		$	4,082,069		$	4,065,144		$	5,896,175	$	5,907,944	$	4,231,788
Units	25,554			25,540			24,781			24,807			24,781			36,139		36,418		25,822
3-Month Occupancy %	85.5			85.2			86.2			85.8			86.2			85.7		85.5		86.0
12-Month Occupancy %	85.7			85.8			85.6			85.9			85.6			85.9		86.1		85.6
EBITDAR	$	392,093		$	390,690		$	360,292		$	383,764		$	360,292		$	402,394	$	402,972	$	364,399
EBITDAR CFC	1.19 x			1.19 x			1.17 x			1.19 x			1.17 x			1.18 x		1.18 x		1.16 x
EBITDARM	$	466,424		$	466,075		$	428,223		$	456,202		$	428,223		$	478,463	$	481,409	$	438,593
EBITDARM CFC	1.41 x			1.42 x			1.39 x			1.42 x			1.39 x			1.40 x		1.41 x		1.40 x
NOI:
Rental and related revenues(4)	$	85,330		$	83,800		$	97,511		$	326,124		$	324,534
DFL income	12,716			13,282			12,200			52,891			49,438
Operating expenses(4)(5)	(315		)	(136		)	(13,274		)	(1,002		)	(26,500		)
	$	97,731		$	96,946		$	96,437		$	378,013		$	347,472
Adjusted NOI:
Straight-line rents	(6,844		)	(9,141		)	(8,176		)	(33,718		)	(21,746		)
Below market lease intangibles, net	(631		)	(631		)	(621		)	(2,524		)	(2,929		)
DFL accretion	(2,546		)	(1,482		)	(2,302		)	(9,052		)	(10,641		)
	$	87,710		$	85,692		$	85,338		$	332,719		$	312,156

(1)EBITDAR, EBITDARM and their respective CFCs are not presented for the disaggregated HCR ManorCare senior housing and post-acute/skilled nursing portfolios as the combined portfolio is cross-collateralized under a single master lease. See HCR ManorCare Leased Portfolio Summary on page 17 of this report.

(2)EBITDAR, EBITDARM and the related CFCs do not apply to the 21 properties operated under a RIDEA structure.

(3)Amounts are presented as originally reported, without giving effect to discontinued operations.

(4)The quarter and year to date ended December 31, 2010 include increases to revenues of $15.7 million and $29.4 million, respectively, and operating expenses of $13.2 million and $25.9 million, respectively, as a result of consolidating the operations for 27 Sunrise managed properties beginning August 31, 2010 through October 31, 2010 (the date that HCP controlled the four VIEs that lease these 27 properties); for additional information regarding these VIEs see Note 21 to the Consolidated Financial Statements for the year ended December 31, 2011 included in the Company’s Annual Report on Form 10-K filed with the SEC.

(5)Excludes certain non-property specific operating expenses allocated to certain segments.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

15

Owned Post-Acute/Skilled Nursing Portfolio

As of and for the year ended December 31, 2011, dollars in thousands

Investments

Leased	Property					Average Age		Occupancy	EBITDAR			EBITDARM
Properties	Count	Investment		NOI		(Years)	Beds	%	Amount		CFC	Amount		CFC
Operating leases	45	$	245,304	$	37,756	27	5,316	84.8	$	67,663	1.84 x	$	88,101	2.40 x
HCR ManorCare DFLs(1)	268		5,300,168		360,462	33	36,487	87.6		N/A	N/A		N/A	N/A
Leased properties	313	$	5,545,472	$	398,218	32	41,803	87.2
Debt				Interest
Investments		Investment		Income
HCR ManorCare(2)		$	—	$	54,303
Genesis HealthCare(3)		—		43,007
Other		9,746		1,140
		$	9,746	$	98,450
Total		$	5,555,218	$	496,668

Operator Concentration(4)

						NOI and
	Properties		Investment			Interest Income					Occupancy	EBITDAR	EBITDARM
Operator	Count	% Pooled	Amount		%	Amount			%	Beds	%	CFC(1)	CFC(1)
HCR ManorCare(1)(2)	268	100	$	5,300,168	95	$	414,765		84	36,487	87.6	N/A	N/A
Formation Capital	9	100	63,100		1	6,853			1	934	94.1	2.29 x	2.82 x
Covenant Care	12	100	62,884		1	10,619			2	1,328	84.0	1.98 x	2.56 x
Kindred Healthcare	9	100	38,117		1	8,174			2	1,288	85.4	1.48 x	2.13 x
Trilogy Health Services	5	100	33,351		1	5,514			1	576	85.0	1.86 x	2.29 x
Other	10	60	57,598		1	50,743		(5)	10	1,190	77.4	1.60 x	2.14 x
	313	99	$	5,555,218	100	$	496,668		100	41,803	87.2	1.84 x	2.40 x

(1)EBITDAR, EBITDARM and their respective CFC are not presented for the disaggregated HCR ManorCare senior housing and post-acute/skilled nursing portfolios as the combined portfolio is cross-collateralized under a single master lease. See HCR ManorCare Leased Portfolio Summary on page 17 of this report.

(2)On April 7, 2011, the Company completed the acquisition of HCR ManorCare’s real estate assets. At closing of the HCR ManorCare Acquisition, the Company’s debt investments in HCR ManorCare were extinguished. For additional information regarding the HCR ManorCare Acquisition see Note 3 to the Consolidated Financial Statements for the year ended December 31, 2011 included in the Company’s Annual Report on Form 10-K filed with the SEC.

(3)On April 1, 2011, the Company’s debt investments in Genesis HealthCare were prepaid.

(4)Property count, beds, occupancy and CFCs are presented for leased properties and exclude debt investments.

(5)Other includes $43 million in interest income related to debt investments in Genesis HealthCare that were prepaid April 1, 2011. For additional information regarding Genesis HealthCare see Note 7 to the Consolidated Financial Statements for the year ended December 31, 2011 included in the Company’s Annual Report on Form 10-K filed with the SEC.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

16

Owned Post-Acute/Skilled Nursing Portfolio

Dollars in thousands

Portfolio Trends

	Same Property Leased Portfolio															Total Leased Portfolio
	As of and for the Quarter Ended									As of and for the YTD Period Ended						As of and for the Twelve Months Ended
	12/31/11			09/30/11			12/31/10			12/31/11			12/31/10			12/31/11(1)		09/30/11(1)(2)		12/31/10(2)
Property count	45			45			45			45			45			313		313		45
Investment	$	245,304		$	244,738		$	244,738		$	245,304		$	244,738		$	5,545,472	$	5,512,400	$	244,738
Beds	5,316			5,286			5,361			5,316			5,331			41,803		41,773		5,331
3-Month Occupancy %	84.9			85.5			85.7			84.9			85.7			86.6		87.1		85.7
12-Month Occupancy %	84.8			85.4			85.4			84.8			85.4			87.2		87.4		85.4
EBITDAR	$	67,663		$	64,805		$	54,500		$	67,663		$	54,500		$	67,663	$	64,805	$	54,500
EBITDAR CFC	1.84 x			1.78 x			1.52 x			1.84 x			1.52 x			1.84 x		1.78 x		1.52 x
EBITDARM	$	88,101		$	84,856		$	74,097		$	88,101		$	74,097		$	88,101	$	84,856	$	74,097
EBITDARM CFC	2.40 x			2.32 x			2.06 x			2.40 x			2.06 x			2.40 x		2.32 x		2.06 x
Quality Mix	66.3%			65.4%			61.0%			66.3%			61.0%			68.5%		68.3%		61.0%
NOI:
Rental revenues	$	9,508		$	9,548		$	9,400		$	38,003		$	37,242
Operating expenses(3)	(118		)	(28		)	(7		)	(187		)	(155		)
	9,390			9,520			9,393			37,816			37,087
Adjusted NOI:
Straight-line rents	(176		)	(206		)	(315		)	(967		)	(1,162		)
	$	9,214		$	9,314		$	9,078		$	36,849		$	35,925

HCR ManorCare Leased Portfolio Summary
As of and for the year ended December 31, 2011, dollars in thousands
Investment	Property						Adjusted			Facility EBITDAR			Facility EBITDARM
Summary	Count		Investment(4)		NOI(5)		NOI		Occupancy	Amount		CFC	Amount		CFC
Assisted living	66		$	823,939	$	50,884	$	42,120	82.4%	N/A		N/A	N/A		N/A
Post-acute/skilled	268		5,300,168		360,462		304,407		87.6%	N/A		N/A	N/A		N/A
Total	334		$	6,124,107	$	411,346	$	346,527	86.9%	$	646,711	1.37 x	$	827,757	1.75 x
	12/31/11		09/30/11		12/31/10
Quality mix	70.9%	(6)	70.8%		71.2%
HCR ManorCare OpCo (guarantor) fixed charge coverage(7)							1.66 x

(1)EBITDAR, EBITDARM, their respective CFC and quality mix are not presented for the disaggregated HCR ManorCare senior housing and post-acute/skilled nursing portfolios as the combined portfolio is cross-collateralized under a single master lease. For additional information see HCR ManorCare Leased Portfolio Summary.

(2)Amounts are presented as originally reported, without giving effect to discontinued operations.

(3)Excludes certain non-property specific operating expenses allocated to certain segments.

(4)The Company’s total investment in HCR ManorCare includes aggregated accumulated DFL accretion of $107.1 million as of December 31, 2011.

(5)Assisted living and post-acute/skilled NOI includes reductions of $5.2 million and $37.0 million, respectively, related to HCP’s equity interest in HCR ManorCare OpCo.

(6)Private-pay and Medicare revenues as a percentage of total revenues are 30.8% and 40.1%, respectively.

(7)HCR ManorCare OpCo (guarantor) fixed charge coverage is based on EBITDAR for the trailing 12 months, is one quarter in arrears from the date presented and includes home health and hospice EBITDAR and corporate general and administrative expenses, excluding HCR ManorCare’s non-recurring expenses associated with the sale of its real estate to HCP. The fixed charges include the most recent monthly cash rent annualized and cash interest expense based on the trailing 12 months and are one quarter in arrears from the date presented.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

17

Owned Life Science Portfolio

As of and for the year ended December 31, 2011, dollars and square feet in thousands

Investments

	Property					Average	Square
Leased Properties	Count	Investment		NOI		Age (Years)	Feet	Occupancy %
San Francisco	74	$	2,564,360	$	178,150	17	4,576	89.5
San Diego	20	575,374		44,279		18	1,553	86.8
Utah	10	119,569		12,926		11	669	100.0
	104	$	3,259,303	$	235,355	17	6,798	89.9

Tenant Concentration

	Annualized Revenues			Square Feet
Tenant	Amount		%	Amount	%
Amgen	$	41,316	19	684	11
Genentech	37,528		17	794	13
Rigel Pharmaceuticals	12,799		6	147	2
Exelixis, Inc.	12,766		6	295	5
Takeda	9,926		4	188	3
LinkedIn Corporation	8,048		4	303	5
Google	7,271		3	248	4
Myriad Genetics	7,217		3	310	5
General Atomics	5,593		3	281	5
ARUP	5,418		2	324	5
Other	73,656		33	2,539	42
	$	221,538	100	6,113	100

Portfolio Trends

	Same Property Leased Portfolio															Total Leased Portfolio
	As of and for the Quarter Ended									As of and for the YTD Period Ended						At the Period Ended
	12/31/11			09/30/11			12/31/10			12/31/11			12/31/10			12/31/11		09/30/11(1)		12/31/10(1)
Property count	96			96			96			95			95			104		104		98
Investment	$	3,084,175		$	3,087,987		$	3,076,144		$	3,054,991		$	3,046,960		$	3,259,303	$	3,263,062	$	3,135,271
Square feet	6,406			6,406			6,405			6,320			6,319			6,798		6,798		6,508
Occupancy %	92.8			92.9			91.3			92.7			91.2			89.9		90.0		90.3
NOI:
Rental and related revenues	$	60,593		$	59,072		$	60,022		$	236,996		$	235,675
Tenant recoveries	10,413			9,993			9,817			39,671			39,375
Operating expenses(2)	(12,401		)	(11,573		)	(11,441		)	(45,570		)	(45,613		)
	$	58,605		$	57,492		$	58,398		$	231,097		$	229,437
Adjusted NOI:
Straight-line rents	(3,512		)	(3,065		)	(4,214		)	(14,430		)	(15,395		)
Above (below) market lease intangibles, net	(341		)	(337		)	273			(1,053		)	(394		)
Lease termination fees	(2,244		)	(1,589		)	(2,500		)	(7,011		)	(7,267		)
	$	52,508		$	52,501		$	51,957		$	208,603		$	206,381

(1)Amounts are presented as originally reported, without giving effect to discontinued operations.

(2)Excludes certain non-property specific operating expenses allocated to certain segments and activities of assets that have been placed in redevelopment.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

18

Owned Life Science Portfolio

Dollars and square feet in thousands, except dollars per square foot

Selected Lease Expirations Data (next 3 years):

	Total					San Francisco			San Diego			Utah
	Square Feet		Annualized Revenues			Square	Annualized		Square	Annualized		Square	Annualized
Year	Amount	%	Amount		%	Feet	Revenues		Feet	Revenues		Feet	Revenues
2012(1)	185	3	$	3,660	2	90	$	1,409	95	$	2,251	—	$	—
2013	418	7	10,595		5	352	9,254		66	1,341		—	—
2014	275	5	8,482		4	210	6,362		65	2,120		—	—
Thereafter	5,235	85	198,801		89	3,444	150,346		1,122	35,335		669	13,120
	6,113	100	$	221,538	100	4,096	$	167,371	1,348	$	41,047	669	$	13,120

Leasing Activity	Leased		Annualized		%		HCP Tenant		Leasing		Average	Retention
	Square		Base Rent Per		Change		Improvements		Costs Per		Lease Term	Rate
	Feet		Square Foot		In Rents		Per Square Foot		Square Foot		(Months)	YTD
Leased Square Feet as of December 31, 2010	5,876		$	36.20
Acquisitions	140		33.30
Expirations	(197	)	19.60
Renewals, amendments and extensions	112		18.83		(1.5	)	$	6.70	$	3.14	28	57.0
New leases and expansions	120		19.62				12.86		10.29		74
Leased Square Feet as of March 31, 2011	6,051		$	36.23
Expirations	(4	)	24.00
Renewals, amendments and extensions	4		24.00		—		$	—	$	—	12	57.8
New leases and expansions	15		12.93				25.47		7.17		59
Leased Square Feet as of June 30, 2011	6,066		$	36.39
Expirations	(198	)	42.20
Renewals, amendments and extensions	70		24.07		(10.7	)	$	14.23	$	4.57	55	46.5
New leases and expansions	179		20.14				8.18		7.40		54
Leased Square Feet as of September 30, 2011	6,117		$	35.86
Expirations	(270	)	19.39
Renewals, amendments and extensions	224		28.20		30.0		$	6.97	$	9.61	109	61.2
New leases and expansions	225		29.87				23.86		15.16		115
Terminations	(183	)	18.75
Leased Square Feet as of December 31, 2011	6,113		$	36.24

(1)Includes month-to-month and holdover leases.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

19

Owned Medical Office Portfolio

As of and for the year ended December 31, 2011, dollars and square feet in thousands

Investments

	Property					Average
Leased Properties	Count	Investment		NOI		Age (Years)	Square Feet	Occupancy %
On-Campus	143	$	1,834,899	$	154,965	20	10,842	91.7
Off-Campus	45	462,319		37,831		19	2,269	90.6
	188	$	2,297,218	$	192,796	20	13,111	91.5

Portfolio Trends

	Same Property Leased Portfolio															Total Leased Portfolio
	As of and for the Quarter Ended									As of and for the YTD Period Ended						At the Period Ended
	12/31/11			09/30/11			12/31/10			12/31/11			12/31/10			12/31/11		09/30/11(1)		12/31/10(1)
Property count	184			184			184			182			182			188		188		187
Investment	$	2,217,783		$	2,205,942		$	2,181,735		$	2,198,195		$	2,162,338		$	2,297,218	$	2,285,159	$	2,226,076
Square feet	12,817			12,811			12,810			12,713			12,707			13,111		13,104		12,965
Occupancy %	91.3			90.7			90.9			91.3			90.8			91.5		91.0		91.0
NOI:
Rental and related revenues	$	66,777		$	66,604		$	66,473		$	264,330		$	260,661
Tenant recoveries	10,520			12,330			11,406			45,192			46,632
Operating expenses(2)	(28,318		)	(31,266		)	(29,336		)	(118,912		)	(121,574		)
	$	48,979		$	47,668		$	48,543		$	190,610		$	185,719
Adjusted NOI:
Straight-line rents	(810		)	(971		)	(1,095		)	(5,065		)	(3,160		)
Below market lease intangibles, net	(84		)	(27		)	(476		)	(130		)	(2,178		)
Lease termination fees	—			—			—			—			(3		)
	$	48,085		$	46,670		$	46,972		$	185,415		$	180,378

(1)   Amounts are presented as originally reported, without giving effect to discontinued operations.

(2)   Excludes certain non-property specific operating expenses allocated to certain segments and activities of assets that have been placed in redevelopment.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

20

Owned Medical Office Portfolio

Square feet in thousands

Leasing Activity

	Leased		Annualized		%	HCP Tenant		Leasing		Average	Retention
	Square		Base Rent Per		Change	Improvements		Costs Per		Lease Term	Rate
	Feet		Square Foot		In Rents(1)	Per Square Foot		Square Foot		(Months)	YTD
Leased Square Feet as of December 31, 2010	11,798		$	21.82
Acquisitions	132		18.74
Expirations	(569	)	24.57
Renewals, amendments and extensions	462		23.43		1.0	$	6.16	$	4.46	85	81.2
New leases	111		21.44			18.94		5.09		84
Terminations	(16	)	13.91
Leased Square Feet as of March 31, 2011	11,918		$	21.86
Expirations	(321	)	21.97
Renewals, amendments and extensions	254		22.06		1.1	$	5.91	$	2.32	50	80.4
New leases	82		20.68			20.36		4.12		59
Terminations	(6	)	16.81
Leased Square Feet as of June 30, 2011	11,927		$	21.94
Expirations	(381	)	22.28
Renewals, amendments and extensions	277		22.80		0.7	$	8.61	$	2.70	56	78.1
New leases	104		20.04			22.50		5.35		64
Terminations	(9	)	22.77
Leased Square Feet as of September 30, 2011	11,918		$	22.07
Expirations	(490	)	22.68
Renewals, amendments and extensions	420		22.18		0.4	$	6.73	$	2.35	55	80.2
New leases	173		18.69			21.88		4.26		69
Terminations	(20	)	18.28
Leased Square Feet as of December 31, 2011	12,001		$	22.13

(1)  For comparative purposes, the calculation reflects adjustments for leases that converted to a different lease type upon renewal, amendment or extension of the original lease.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

21

Owned Hospital Portfolio

As of and for the year ended December 31, 2011, dollars in thousands

Investments

Leased	Property					Average		Occupancy	EBITDAR(1)			EBITDARM(1)
Properties	Count	Investment		NOI		Age (Years)	Beds	%(1)	Amount		CFC	Amount		CFC
Acute care	5	$	452,672	$	57,486	35	1,578	52.6	$	283,152	4.90 x	$	308,709	5.34 x
Rehab	7	96,784		8,036		21	520	57.7	28,082		3.18 x	32,078		3.64 x
Specialty	2	63,725		5,186		28	37	—	18,931		3.50 x	21,163		3.92 x
LTACH	3	35,205		8,090		18	244	42.2	5,767		0.81 x	8,887		1.25 x
	17	$	648,386	$	78,798	25	2,379	52.2	$	335,932	4.25 x	$	370,837	4.69 x
Debt				Interest
Investments		Investment		Income
Acute care		$	14,600	$	1,236
Specialty(2)		75,650		—
		$	90,250	$	1,236
Total		$	738,636	$	80,034

Operator Concentration(3)

						NOI and
	Properties		Investment			Interest Income
Operator(1)	Count	% Pooled	Amount		%	Amount		%	Beds
Tenet Healthcare	3	—	$	196,709	27	$	23,055	29	756
HCA	1	—	167,164		23	20,897		26	668
Cirrus Health	2	—	139,375		19	5,187		6	37
Hoag Memorial Hospital Presbyterian	1	—	88,800		12	13,537		17	154
Other	10	70	146,588		19	17,358		22	764
	17	41	$	738,636	100	$	80,034	100	2,379

(1)Certain operators in HCP’s hospital portfolio are not required under their respective leases to provide operational data.

(2)Represents a senior secured loan to Cirrus that was placed on non-accrual status effective January 1, 2011.  For additional information regarding the senior secured loan to Cirrus see Note 7 to the Consolidated Financial Statements for the year ended December 31, 2011 included in the Company’s Annual Report on Form 10-K filed with the SEC.

(3)Property count and beds are presented for leased properties and exclude debt investments.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

22

Owned Hospital Portfolio

Dollars in thousands

Portfolio Trends

	Same Property Leased Portfolio															Total Leased Portfolio
	As of and for the Quarter Ended									As of and for the YTD Period Ended						As of and for the Twelve Months Ended
	12/31/11			09/30/11			12/31/10			12/31/11			12/31/10			12/31/11		09/30/11(1)		12/31/10(1)
Property count	16			16			16			16			16			17		17		17
Investment	$	608,641		$	608,641		$	608,641		$	608,641		$	608,641		$	648,386	$	648,386	$	648,346
Beds	2,379			2,379			2,361			2,379			2,361			2,379		2,379		2,368
3-Month Occupancy %	48.4			53.1			49.7			48.4			49.7			48.4		53.1		52.6
12-Month Occupancy %	52.2			52.6			57.2			52.2			57.2			52.2		52.6		57.7
EBITDAR	$	326,632		$	311,906		$	303,039		$	326,632		$	303,039		$	335,932	$	321,040	$	313,998
EBITDAR CFC	4.29 x			4.08 x			4.75 x			4.29 x			4.75 x			4.25 x		4.05 x		4.71 x
EBITDARM	$	360,305		$	344,912		$	335,500		$	360,305		$	335,500		$	370,837	$	355,405	$	347,323
EBITDARM CFC	4.73 x			4.51 x			5.26 x			4.73 x			5.26 x			4.69 x		4.48 x		5.22 x
NOI:
Rental and related revenues	$	20,246		$	20,091		$	19,888		$	79,973		$	80,013
Operating expenses	(916		)	(1,226		)	(1,025		)	(4,328		)	(4,831		)
	$	19,330		$	18,865		$	18,863		$	75,645		$	75,182
Adjusted NOI:
Straight-line rents	(184		)	(192		)	(275		)	(904		)	(3,683		)
Below market lease intangibles, net	(192		)	(193		)	(193		)	(771		)	(771		)
	$	18,954		$	18,480		$	18,395		$	73,970		$	70,728

(1)  Amounts are presented as originally reported, without giving effect to discontinued operations.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

23

Investment Management Platform

As of and for the year ended December 31, 2011, dollars in thousands

Unconsolidated Institutional Joint Ventures	Primary Segment	Date Established/ Acquired	HCP’s Ownership Percentage		Joint Venture’s Investment		HCP’s Net Equity Investment(1)		HCP’s Investment Management Fee Income(2)		Initial Term (in years)
HCP Ventures III	Medical office	October-06		30%(3)	$	142,619	$	8,720	$	396	10
HCP Ventures IV	Medical office	April-07		20%	656,057		35,272		1,602		10
HCP Life Science	Life science	August-07	50%-63%		144,479		66,522		4		97-98
					$	943,155	$	110,514	$	2,002

Balance Sheets(4)
	December 31, 2011						December 31, 2010
	Medical Office			Life Science			Medical Office			Life Science
ASSETS
Real estate:
Buildings and improvements	$	679,131		$	28,762		$	665,925		$	37,489
Land	68,004			8,271			67,897			8,271
Accumulated depreciation and amortization	(114,698		)	(15,331		)	(94,901		)	(23,428		)
Net real estate	632,437			21,702			638,921			22,332
Cash and cash equivalents and restricted cash	8,459			2,071			15,275			1,876
Intangible assets, net	36,573			—			42,805			—
Other assets, net	20,216			1,349			20,112			1,684
Total assets	$	697,685		$	25,122		$	717,113		$	25,892
LIABILITIES AND MEMBERS’ CAPITAL
Mortgage debt	$	466,750		$	6,573		$	469,061		$	9,882
Intangible liabilities, net	10,952			—			12,523			—
Accounts payable, accrued liabilities and deferred revenue	14,497			974			12,458			1,016
Total liabilities	492,199			7,547			494,042			10,898
HCP’s capital	32,207			9,567			36,158			7,918
Partners’ capital	173,279			8,008			186,913			7,076
Total liabilities and members’ capital	$	697,685		$	25,122		$	717,113		$	25,892

(1)The carrying value of investments in unconsolidated joint ventures is based on the amount the Company paid to purchase the joint venture interest, which is different from the Company’s capital balance as reflected at the joint venture level as the records of the unconsolidated joint venture are reflected at their historical cost. These differences in basis are generally amortized over the lives of the related assets and liabilities and included in the Company’s share of equity in earnings of the respective joint venture.

(2)Investment management fee income presented on the Company’s consolidated income statement for the year ended December 31, 2011 of $2.0 million includes $70,000 from HCP Ventures II, an unconsolidated senior housing joint venture. On January 14, 2011, the Company acquired its partner’s 65% interest, becoming the sole owner of the portfolio. For additional information see Note 8 to the Consolidated Financial Statements for the year ended December 31, 2011 included in the Company’s Annual Report on Form 10-K filed with the SEC.

(3)The Company owns an 85% interest in HCP Birmingham Portfolio LLC, which owns a 30% interest in HCP Ventures III.

(4)Financial information is combined by primary segment of each joint venture (i.e., HCP Ventures III and HCP Ventures IV are combined under the medical office columns).

See Reporting Definitions and Reconciliations of Non-GAAP Measures

24

Investment Management Platform

In thousands

Statement of Operations and Funds From Operations(1)
	Three Months Ended December 31, 2011						Three Months Ended December 31, 2010
	Medical Office			Life Science			Medical Office			Life Science
Revenues:
Rental and related revenues	$	14,515		$	2,408		$	16,248		$	2,683
Tenant recoveries	3,708			313			3,931			354
Total revenues	18,223			2,721			20,179			3,037
Costs and expenses:
Depreciation and amortization	7,073			385			7,130			734
Operating	7,610			380			7,838			374
General and administrative	793			75			921			82
Total costs and expenses	15,476			840			15,889			1,190
Other income (expense):
Other income, net	—			—			2			—
Interest expense	(6,764		)	(127		)	(6,837		)	(186		)
Net income (loss)	$	(4,017	)	$	1,754		$	(2,545	)	$	1,661
Depreciation and amortization	7,073			385			7,130			734
FFO	$	3,056		$	2,139		$	4,585		$	2,395
HCP’s pro rata share of FFO	$	730		$	1,238		$	1,042		$	1,397
Selected supplemental cash flow information:
Amortization of above and below market lease intangibles, net	$	(190	)	$	—		$	(137	)	$	—
Amortization of debt issuance costs, net	189			8			189			8
Straight-line rents	1,114			46			(172		)	116
Leasing costs and tenant and capital improvements	(2,683		)	(146		)	(2,372		)	(68		)
	Year Ended December 31, 2011						Year Ended December 31, 2010
	Medical Office			Life Science			Medical Office			Life Science
Revenues:
Rental and related revenues	$	61,747		$	10,498		$	67,387		$	10,101
Tenant recoveries	15,466			1,224			16,886			1,441
Total revenues	77,213			11,722			84,273			11,542
Costs and expenses:
Depreciation and amortization	28,120			1,663			30,902			2,573
Operating	32,424			1,505			32,900			1,525
General and administrative	3,097			122			3,812			128
Total costs and expenses	63,641			3,290			67,614			4,226
Other income (expense):
Other income, net	3			—			12			—
Interest expense	(26,978		)	(597		)	(27,371		)	(827		)
Net income (loss)	$	(13,403	)	$	7,835		$	(10,700	)	$	6,489
Depreciation and amortization	28,120			1,663			30,902			2,573
FFO	$	14,717		$	9,498		$	20,202		$	9,062
HCP’s pro rata share of FFO	$	3,428		$	5,532		$	4,545		$	5,263
Selected supplemental cash flow information:
Amortization of above and below market lease intangibles, net	$	(640	)	$	—		$	(310	)	$	—
Amortization of debt issuance costs, net	758			32			758			32
Straight-line rents	329			96			(1,726		)	358
Leasing costs and tenant and capital improvements	(8,325		)	(1,030		)	(7,296		)	(2,081		)

(1)  Financial information is combined by primary segment of each joint venture (i.e., HCP Ventures III and HCP Ventures IV are combined under the medical office columns).

See Reporting Definitions and Reconciliations of Non-GAAP Measures
	25

Investment Management Platform

In thousands

Net Operating Income(1)
	Three Months Ended December 31, 2011					Three Months Ended December 31, 2010
	Medical Office			Life Science		Medical Office			Life Science
Net income (loss)	$	(4,017	)	$	1,754	$	(2,545	)	$	1,661
Depreciation and amortization	7,073			385		7,130			734
General and administrative	793			75		921			82
Other income, net	—			—		(2		)	—
Interest expense	6,764			127		6,837			186
NOI	$	10,613		$	2,341	$	12,341		$	2,663
Straight-line rents	1,114			46		(172		)	116
Amortization of above (below) market lease intangibles, net	(190		)	—		(137		)	—
Adjusted NOI	$	11,537		$	2,387	$	12,032		$	2,779
HCP’s pro rata share of NOI	$	2,406		$	1,353	$	2,757		$	1,549
HCP’s pro rata share of adjusted NOI	$	2,583		$	1,378	$	2,682		$	1,608
	Year Ended December 31, 2011					Year Ended December 31, 2010
	Medical Office			Life Science		Medical Office			Life Science
Net income (loss)	$	(13,403	)	$	7,835	$	(10,700	)	$	6,489
Depreciation and amortization	28,120			1,663		30,902			2,573
General and administrative	3,097			122		3,812			128
Other income, net	(3		)	—		(12		)	—
Interest expense	26,978			597		27,371			827
NOI	$	44,789		$	10,217	$	51,373		$	10,017
Straight-line rents	329			96		(1,726		)	358
Amortization of above (below) market lease intangibles, net	(640		)	—		(310		)	—
Lease termination fees	(31		)	—		(429		)	—
Adjusted NOI	$	44,447		$	10,313	$	48,908		$	10,375
HCP’s pro rata share of NOI	$	10,086		$	5,942	$	11,429		$	5,811
HCP’s pro rata share of adjusted NOI	$	9,979		$	6,000	$	10,868		$	5,993

(1)   Financial information is combined by primary segment of each joint venture (i.e., HCP Ventures III and HCP Ventures IV are combined under the medical office columns).

See Reporting Definitions and Reconciliations of Non-GAAP Measures
	26

Investment Management Platform

As of and for the year ended December 31, 2011, dollars and square feet in thousands

	Property					Adjusted		Average	Square
HCP Ventures III	Count	Investment		NOI		NOI		Age (Years)	Feet	Occupancy %
Medical office:
On-Campus	9	$	109,464	$	9,113	$	8,785	11	619	98.7
Off-Campus	4	33,155		2,162		2,106		11	183	85.3
	13	$	142,619	$	11,275	$	10,891	11	802	95.7

	Property					Adjusted		Average	Square
HCP Ventures IV	Count	Investment		NOI		NOI		Age (Years)	Feet	Occupancy %(1)
Medical office:
On-Campus	22	$	215,261	$	10,371	$	10,416	23	1,103	75.2
Off-Campus	31	359,413		19,740		18,840		20	1,483	86.1
Hospital:
LTACH	1	12,193		112		112		5	N/A	N/A
Specialty	3	69,190		3,291		4,188		7	N/A	N/A
	57	$	656,057	$	33,514	$	33,556	20

	Property					Adjusted		Average	Square
HCP Life Science	Count	Investment		NOI		NOI		Age (Years)	Feet	Occupancy %
San Francisco	2	$	74,697	$	4,718	$	4,906	15	147	100.0
San Diego	2	69,782		5,499		5,407		16	131	90.3
	4	$	144,479	$	10,217	$	10,313	15	278	95.4
Total	74	$	943,155	$	55,006	$	54,760

(1)Certain operators in the Investment Management Platform hospital portfolio are not required under their respective leases to provide operational data.

See Reporting Definitions and Reconciliations of Non-GAAP Measures
	27

Reporting Definitions and Reconciliations of Non-GAAP Measures

Adjusted Fixed Charge Coverage.  Adjusted EBITDA divided by Fixed Charges. The Company uses Adjusted Fixed Charge Coverage, a non-GAAP financial measure, as a measure of liquidity. The Company believes Adjusted Fixed Charge Coverage provides investors, particularly fixed income investors, relevant and useful information because it measures the Company’s ability to meet its interest payments on outstanding debt and pay dividends to its preferred stockholders. The Company’s various debt agreements contain covenants that require the Company to maintain ratios similar to Adjusted Fixed Charge Coverage and credit rating agencies utilize similar ratios in evaluating and determining the credit rating on certain debt instruments of the Company. However, since this ratio is derived from Adjusted EBITDA and Fixed Charges, its usefulness is limited by the same factors that limit the usefulness of Adjusted EBITDA and Fixed Charges. Further, the Company’s computation of Adjusted Fixed Charge Coverage may not be comparable to similar fixed charge coverage ratios reported by other companies. The Company has provided reconciliations of this measure to the most comparable GAAP measure in this supplemental information package and for certain historical trend information on page 6, such reconciliations are available in the Company’s Current Reports on Form 8-K filed with the SEC dated February 15, 2011 (2010 metrics), February 12, 2010 (2009 metrics), February 10, 2009 (2008 metrics), February 11, 2008 (2008 and 2007 metrics) and July 30, 2007 (Pre-CNL Acquisition metrics).

The following table details the calculation of Adjusted Fixed Charge Coverage:

In thousands

	Three Months Ended December 31,				Year Ended December 31,
	2011		2010		2011			2010
Adjusted EBITDA	$	386,599	$	283,495	$	1,473,258		$	1,024,530
Interest expense:
Continuing operations	101,433		68,354		419,337			288,649
Discontinued operations	—		—		(1		)	8
HCP’s share of interest expense from the Investment Management Platform	1,569		4,978		6,312			19,907
Capitalized interest	7,007		6,150		26,402			21,664
Preferred stock dividends	5,282		5,282		21,130			21,130
Fixed charges	$	115,291	$	84,764	$	473,180		$	351,358
Adjusted fixed charge coverage	3.4 x		3.3 x		3.1 x			2.9 x

Annualized Revenues.  The most recent monthly base rent (including additional rent floors), cash income from direct financing leases and/or interest income annualized for 12 months. Annualized Revenues for operating properties under a RIDEA structure are calculated based on the most recent monthly NOI annualized for 12 months. Annualized Revenues do not include tenant recoveries, additional rents in excess of floors and non-cash revenue adjustments (i.e., straight-line rents, amortization of above and below market lease intangibles, DFL interest accretion and deferred revenues). The Company uses Annualized Revenues for the purpose of determining Relationship Concentrations, Lease Expirations and Debt Investment Maturities.

Assets Held for Sale.  Assets of discontinued operations in accordance with Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets.

Assisted Living Facility (“ALF”).  A senior housing facility that predominantly consists of assisted living units is classified by the Company as an ALF.

Beds/Units/Square Feet.  Senior housing facilities are measured in units (e.g., studio, one or two bedroom units). Life science facilities and medical office buildings are measured in square feet. Post-acute/skilled nursing facilities and hospitals are measured in licensed bed count.

Cash Flow Coverage (“CFC”).  Facility EBITDAR or Facility EBITDARM for the most recent 12 months of available data divided by the Same Period Rent. Cash Flow Coverage is a supplemental measure of a property’s ability to generate cash flows for the operator/tenant (not the Company) to meet the operator’s/tenant’s related rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of Facility EBITDAR or Facility EBITDARM. The coverages shown exclude newly completed facilities under start-up, vacant facilities and facilities for which data is not available or meaningful.

Consolidated Assets.  Total assets as reported in the Company’s consolidated financial statements.

Consolidated Debt.  The carrying amount of bank line of credit, bridge and term loans (if applicable), senior unsecured notes, mortgage and other secured debt, and other debt as reported in the Company’s consolidated financial statements.

Consolidated Gross Assets.  The carrying amount of total assets, excluding investments in and advances to unconsolidated joint ventures, after adding back accumulated depreciation and amortization, as reported in the Company’s consolidated financial statements.

Consolidated Secured Debt.  Mortgage and other secured debt secured by real estate excluding debt on assets held for sale as reported in the Company’s consolidated financial statements.

Continuing Care Retirement Community (“CCRC”).  A senior housing facility which provides at least three levels of care (i.e., independent living, assisted living and skilled nursing) is classified by the Company as a CCRC.

Debt Investments.  Loans secured by a direct interest in real estate and mezzanine loans.

Debt Service.  The periodic payment of interest expense and principal amortization on secured loans.

28

Reporting Definitions and Reconciliations of Non-GAAP Measures

Development.  Includes ground-up construction and redevelopments.

Direct Financing Lease (“DFL”).  The Company uses the direct finance method of accounting to record income from DFLs. For leases accounted for as DFLs, future minimum lease payments are recorded as a receivable. The difference between the future minimum lease payments and the estimated residual values less the cost of the properties is recorded as unearned income. Unearned income is deferred and amortized to income over the lease terms to provide a constant yield.

Estimated Completion Date.For development projects, management’s estimate of the date the core and shell structure improvements are expected to be or have been completed. For redevelopment projects, management’s estimate of the time in which major construction activity in relation to the scope of the project has been substantially completed.

EBITDA and Adjusted EBITDA.  The real estate industry uses earnings before interest, taxes, depreciation and amortization (“EBITDA”), a non-GAAP financial measure, as a measure of both operating performance and liquidity. Adjusted EBITDA is calculated as EBITDA excluding impairments and gains or losses from real estate dispositions. The Company uses EBITDA and Adjusted EBITDA to measure both its operating performance and liquidity. The Company considers Adjusted EBITDA to provide investors relevant and useful information because it permits investors to view income from its operations on an unleveraged basis before the effects of taxes, non-cash depreciation and amortization, impairments, impairment recoveries, and gains or losses from real estate dispositions. By excluding interest expense, Adjusted EBITDA allows investors to measure the Company’s operating performance independent of its capital structure and indebtedness and, therefore, allows for a more meaningful comparison of its operating performance between quarters as well as annual periods and to compare its operating performance to that of other companies, both in the real estate industry and in other industries. As a liquidity measure, the Company believes that EBITDA and Adjusted EBITDA help investors analyze the Company’s ability to meet its interest payments on outstanding debt and to make preferred dividend payments. The Company believes investors should consider EBITDA and Adjusted EBITDA, in conjunction with net income (the primary measure of the Company’s performance) and the other required GAAP measures of its performance and liquidity, to improve their understanding of the Company’s operating results and liquidity, and to make more meaningful comparisons of its performance between periods and as against other companies. EBITDA and Adjusted EBITDA have limitations as analytical tools and should be used in conjunction with the Company’s required GAAP presentations. EBITDA and Adjusted EBITDA do not reflect the Company’s historical cash expenditures or future cash requirements for capital expenditures or contractual commitments. While Adjusted EBITDA is a relevant and widely used measure of operating performance and liquidity, it does not represent net income or cash flow from operations as defined by GAAP and it should not be considered as an alternative to those indicators in evaluating operating performance or liquidity. Further, the Company’s computation of EBITDA and Adjusted EBITDA may not be comparable to similar measures reported by other companies.

The following table reconciles Adjusted EBITDA from net income:

In thousands

	Three Months Ended December 31,						Year Ended December 31,
	2011			2010			2011			2010
Net income	$	70,787		$	145,526		$	554,494		$	344,395
Interest expense:
Continuing operations	101,433			68,354			419,337			288,650
Discontinued operations	—			—			(1		)	7
Income taxes:
Continuing operations	960			(1,397		)	1,249			412
Discontinued operations	(30		)	7			(29		)	36
Depreciation and amortization of real estate, in-place lease and other intangibles:
Continuing operations	87,362			77,820			356,834			311,218
Discontinued operations	5			237			561			2,229
Equity income from unconsolidated joint ventures	(13,952		)	(692		)	(46,750		)	(4,770		)
HCP’s share of EBITDA from the Investment Management Platform	3,539			9,172			15,272			40,578
Other joint venture adjustments	14,602			341			42,767			1,907
EBITDA	$	264,706		$	299,368		$	1,343,734		$	984,662
Impairments, net of recoveries	—			—			15,400			59,793
Litigation settlement charge	125,000			—			125,000			—
Gain on sales of real estate	(3,107		)	(15,873		)	(3,107		)	(19,925		)
Gain upon consolidation of joint venture	—			—			(7,769		)	—
Adjusted EBITDA	$	386,599		$	283,495		$	1,473,258		$	1,024,530

Facility EBITDAR (“EBITDAR”).  Earnings before interest, taxes, depreciation, amortization and rent for a particular facility accruing to the operator/tenant of the property (not the Company), for the trailing 12 months and one quarter in arrears from the date presented. The Company uses Facility EBITDAR in determining Cash Flow Coverage and Debt Service Coverage. Facility EBITDAR has limitations as an analytical tool.  Facility EBITDAR does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, Facility EBITDAR does not represent a property’s net income or cash flow from operations and should not be considered an alternative to those indicators. However, the Company receives periodic financial information from operators/tenants regarding the performance of the Company’s facilities under the operator’s/tenant’s management. The Company utilizes Facility EBITDAR as a supplemental measure of the ability of those properties to generate sufficient liquidity to meet related obligations to the Company. Facility EBITDAR includes the greater of (i) contractual management fees or (ii) an imputed management fee of 5% for senior housing facilities and post-acute/skilled nursing facilities and 2% for acute care hospitals which the Company believes represents typical management fees in their respective industries. All facility financial performance data was derived solely from information provided by operators/tenants and borrowers without independent verification by the Company.

29

Reporting Definitions and Reconciliations of Non-GAAP Measures

Facility EBITDARM (“EBITDARM”).  Earnings before interest, taxes, depreciation, amortization, rent and management fees for a particular facility accruing to the operator/tenant of the property (not the Company), for the trailing 12 months and one quarter in arrears from the date presented.  The Company uses Facility EBITDARM in determining Cash Flow Coverage and Debt Service Coverage. Facility EBITDARM has limitations as an analytical tool. Facility EBITDARM does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, Facility EBITDARM does not represent a property’s net income or cash flow from operations and should not be considered an alternative to those indicators. However, the Company receives periodic financial information from operators/tenants regarding the performance of the Company’s facilities under the operator’s/tenant’s management. The Company utilizes Facility EBITDARM as a supplemental measure of the ability of those properties to generate sufficient liquidity to meet related obligations to the Company. All facility financial performance data was derived solely from information provided by operators/tenants and borrowers without independent verification by the Company.

Financial Leverage.Total Debt divided by Total Gross Assets. The Company believes that its Financial Leverage is a meaningful supplemental measure of its financial position, which enables both management and investors to analyze its leverage and to compare its leverage to that of other companies. The Company believes that the ratio of consolidated debt to consolidated gross assets is the most directly comparable GAAP measure to Financial Leverage. The Company’s computation of its Financial Leverage may not be identical to the computations of financial leverage reported by other companies. The Company’s share of total debt is not intended to reflect its actual liability or ability to access assets should there be a default under any or all of such loans or a liquidation of the joint ventures. The Company has provided reconciliations of this measure to the most comparable GAAP measure in this supplemental information package and for certain historical trend information on page 6, such reconciliations are available in the Company’s Current Reports on Form 8-K filed with the SEC dated February 15, 2011 (2010 metrics), February 12, 2010 (2009 metrics), February 10, 2009 (2008 metrics), February 11, 2008 (2008 and 2007 metrics) and July 30, 2007 (Pre-CNL Acquisition metrics).

Fixed Charges.  Total interest expense plus capitalized interest plus preferred stock dividends. The Company uses Fixed Charges to measure its interest payments on outstanding debt and dividends to its preferred stockholders for purposes of presenting Fixed Charge Coverage and Adjusted Fixed Charge Coverage. However, the usefulness of Fixed Charges is limited as, among other things, it does not include all contractual obligations.  The Company’s computation of Fixed Charges should not be considered an alternative to fixed charges as defined by Item 503(d) of Regulation S-K and may not be comparable to fixed charges reported by other companies.

Funds Available for Distribution (“FAD”).  Funds Available for Distribution is defined as FFO as adjusted after excluding the impact of the following: (i) straight-line rents; (ii) amortization of acquired above/below market lease intangibles; (iii) amortization of debt premiums, discounts and issuance costs; (iv) amortization of stock–based compensation expense; (v) accretion and depreciation related to direct financing leases; and (vi) deferred revenues. Further, FAD is computed after deducting recurring capital expenditures, including leasing costs and second generation tenant and capital improvements and includes similar adjustments to compute the Company’s share of FAD from its unconsolidated joint ventures. Other REITs or real estate companies may use different methodologies for calculating FAD, and accordingly, HCP’s FAD may not be comparable to those reported by other REITs. Although HCP’s FAD computation may not be comparable to that of other REITs, management believes FAD provides a meaningful supplemental measure of the Company’s ability to fund its ongoing dividend payments. In addition, management believes that in order to further understand and analyze the Company’s liquidity, FAD should be compared with cash flows as determined in accordance with GAAP and presented in its consolidated financial statements. FAD does not represent cash generated from operating activities determined in accordance with GAAP, and FAD should not be considered as an alternative to net income (determined in accordance with GAAP) as an indication of the Company’s performance, as an alternative to net cash flows from operating activities (determined in accordance with GAAP), or as a measure of the Company’s liquidity.

Funds From Operations (“FFO”).  The Company believes that net income as defined by GAAP is the most appropriate earnings measure.  The Company also believes that Funds From Operations, or FFO, as defined by the National Association of Real Estate Investment Trusts (“NAREIT”), FFO applicable to common shares, Diluted FFO applicable to common shares, and Basic and Diluted FFO per common share are important non-GAAP supplemental measures of operating performance for a real estate investment trust.  Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time.  However, since real estate values have historically risen or fallen with market and other conditions, presentations of operating results for a real estate investment trust that use historical cost accounting for depreciation could be less informative.  Thus, NAREIT created FFO as a supplemental measure of operating performance for real estate investment trusts that excludes historical cost depreciation and amortization, among other items, from net income, as defined by GAAP.  FFO is defined as net income (computed in accordance with GAAP), excluding gains or losses from acquisition and dispositions of depreciable real estate or related interests, impairments of, or related to, depreciable real estate, plus real estate and DFL depreciation and amortization, with adjustments to derive the Company’s pro rata share of FFO from consolidated and unconsolidated joint ventures.  Adjustments for joint ventures are calculated to reflect FFO on the same basis.  The Company believes that the use of FFO, combined with the required GAAP presentations, improves the understanding of operating results of real estate investment trusts among investors and makes comparisons of operating results among such companies more meaningful.  The Company considers FFO to be a useful measure for reviewing comparative operating and financial performance because, by excluding gains or losses related to sales of previously depreciated operating real estate assets and real estate and DFL depreciation and amortization, FFO can help investors compare the operating performance of a real estate investment trust between periods or as compared to other companies.  While FFO is a relevant and widely used measure of operating performance of real estate investment trusts, it does not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company’s liquidity or operating performance. FFO also does not consider the costs associated with capital expenditures related to the Company’s real estate assets nor is FFO necessarily indicative of cash available to fund the Company’s future cash requirements. The Company’s computation of FFO may not be comparable to FFO reported by other real estate investment trusts that do not define the term in accordance with the current NAREIT definition or that interpret the current NAREIT definition differently from the Company. For a reconciliation of FFO to net income, please refer to the slide in this supplemental information package captioned “Consolidated Funds From Operations.”

FFO as adjusted represents FFO before the impact of litigation settlement charges, other impairments, other impairment recoveries and merger-related items.  Merger-related items include estimated acquisition pursuit costs that consist primarily of professional fees and the impact of common stock offering which increases the weighted average shares outstanding, when such proceeds will be used to fund a portion of the cash

30

Reporting Definitions and Reconciliations of Non-GAAP Measures

consideration of the Company’s pending acquisitions.  Management believes FFO as adjusted is a useful alternative measurement.  This measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net income.

NAREIT recently issued updated reporting guidance that directs companies, for their computation of NAREIT FFO, to exclude impairments of depreciable real estate and other assets when write-downs are driven by measurable decreases in the fair value of real estate holdings (e.g., investments in joint ventures that primarily hold real estate). Previously, the Company’s calculation of FFO (consistent with NAREIT’s previous guidance) did not exclude impairments of, or related to, depreciable real estate. Consistent with this current NAREIT reporting guidance, the Company has restated its 2010 FFO amounts.

FFO Payout Ratio.  Dividends declared per common share divided by Diluted FFO per common share for a given period.  The Company believes the FFO Payout Ratio per Common Share provides investors relevant and useful information because it measures the portion of FFO being declared as dividends to common stockholders.  FFO Payout Ratio per Common Share is subject to the same limitations noted in the definition of FFO above.

HCP Life Science.  Includes three unconsolidated joint ventures between the Company and an institutional capital partner for which the Company is the managing member.  HCP Life Science includes the following partnerships: (i) Torrey Pines Science Center LP (50%), (ii) Britannia Biotech Gateway LP (55%) and (iii) LASDK LP (63%).  The unconsolidated joint ventures were acquired as part of the Company’s purchase of Slough Estates USA Inc. on August 1, 2007.

HCP Ventures III.  An unconsolidated joint venture formed on October 27, 2006 between the Company and an institutional capital partner, for which the Company is the managing member and has an effective 25.5% interest.

HCP Ventures IV.  An unconsolidated joint venture formed on April 30, 2007 between the Company and an institutional capital partner, for which the Company is the managing member and has a 20% interest.

Independent Living Facility (“ILF”).  A senior housing facility that predominantly consists of independent living units.

Investment.  Represents (i) the carrying amount of real estate assets, including intangibles, after adding back accumulated depreciation and amortization, excluding assets held for sale and classified as discontinued operations and (ii) the carrying amount of DFLs and debt investments.

Investment Management Platform.  Includes the following unconsolidated joint ventures: (i) HCP Life Science, (ii) HCP Ventures III and (iii) HCP Ventures IV.

Life Science.  Laboratory and office space primarily for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry.

Long-Term Acute Care Hospitals (“LTACHs”).  LTACHs provide care for patients with complex medical conditions that require longer stays and more intensive care, monitoring or emergency back-up than that available in most skilled nursing-based programs.

Net Operating Income from Continuing Operations (“NOI”).  A non-GAAP supplemental financial measure used to evaluate the operating performance of real estate properties and SPP.  The Company defines NOI as rental revenues, including tenant reimbursements, resident fees and services, and income from direct financing leases, less property level operating expenses.  NOI excludes interest income, investment management fee income, depreciation and amortization, interest expense, general and administrative expenses, litigation settlement, impairments, impairment recoveries, other income, net, income taxes, equity income from unconsolidated joint ventures and discontinued operations.  The Company believes NOI provides investors relevant and useful information because it measures the operating performance of the Company’s real estate at the property level on an unleveraged basis.  NOI, as adjusted, is calculated as NOI eliminating the effects of straight-line rents, DFL accretion, amortization of above and below market lease intangibles, and lease termination fees. NOI, as adjusted, is sometimes referred to as “adjusted NOI” or “cash NOI.”  The Company uses NOI and NOI, as adjusted, to make decisions about resource allocations, to assess and compare property level performance, and evaluate SPP.  The Company believes that net income is the most directly comparable GAAP measure to NOI.  NOI should not be viewed as an alternative measure of operating performance to net income as defined by GAAP since it does not reflect the aforementioned excluded items.  Further, NOI may not be comparable to that of other real estate investment trusts, as they may use different methodologies for calculating NOI.

The following table reconciles NOI from net income:

In thousands	Three Months Ended December 31,						Year Ended December 31,
	2011			2010			2011			2010
Net income	$	70,787		$	145,526		$	554,494		$	344,395
Interest income	(665		)	(52,159		)	(99,864		)	(160,163		)
Investment management fee income	(468		)	(911		)	(2,073		)	(4,666		)
Depreciation and amortization	87,362			77,820			356,834			311,218
Interest expense	101,433			68,354			419,337			288,650
General and administrative	19,678			18,008			96,150			83,048
Litigation settlement	125,000			—			125,000			—
Impairments (recoveries)	—			—			15,400			(11,900		)
Other income (expense), net	4,720			(8,667		)	(12,338		)	(15,818		)
Income taxes	960			(1,397		)	1,249			412
Equity income from unconsolidated joint ventures	(13,952		)	(692		)	(46,750		)	(4,770		)
Impairments of investments in unconsolidated joint ventures	—			—			—			71,693
Total discontinued operations, net of taxes	(3,433		)	(16,327		)	(4,162		)	(23,676		)
NOI	$	391,422		$	229,555		$	1,403,277		$	878,423
Straight-line rents	(12,237		)	(14,374		)	(59,173		)	(47,243		)
DFL accretion	(25,499		)	(2,300		)	(74,007		)	(10,641		)
Amortization of above and below market lease intangibles, net	(1,239		)	(1,041		)	(4,510		)	(6,378		)
Lease termination fees	(2,457		)	(2,500		)	(5,873		)	(7,665		)
NOI adjustments related to discontinued operations	—			—			—			27
Adjusted NOI	$	349,990		$	209,340		$	1,259,714		$	806,523

31

Reporting Definitions and Reconciliations of Non-GAAP Measures

Occupancy.  For life science facilities and medical office buildings, occupancy represents the percentage of total rentable square feet leased where rental payments have commenced, including month-to-month leases, as of the end of the period reported. For senior housing facilities, post-acute/skilled nursing facilities and hospitals, occupancy represents the facilities’ average operating occupancy for the trailing 12 months and one quarter in arrears from the date reported. The percentages are calculated based on licensed beds, available beds and units for senior housing facilities, post-acute/skilled nursing facilities and hospitals, respectively. The percentages shown exclude newly completed facilities under lease-up, vacant facilities and facilities for which data is not available or meaningful. All facility financial performance data were derived solely from information provided by operators/tenants and borrowers without independent verification by the Company. For the same property portfolio, occupancy for senior housing facilities, post-acute/skilled nursing facilities and hospitals are presented based on the average operating occupancy for trailing three-month period one quarter in arrears from the date reported.

Owned Portfolio.  Represents owned properties subject to operating leases and DFLs, properties operated under a RIDEA structure and debt investments, and excludes properties under development, including redevelopment, land held for development and real estate owned by the Company’s unconsolidated joint ventures.

Pooled Leases.  Two or more leases to the same operator/tenant or their subsidiaries under which their obligations are combined by virtue of a master lease, or multiple master leases, a pooling agreement, or multiple pooling agreements, or cross-guaranties. For example, Sunrise Senior Living percentage pooled consists of 47 assets under 6 separate pools.

Quality Mix.  Represents non-medicaid revenues as a percent of total revenues for the trailing 12 months and is one quarter in arrears from the period presented.

Redevelopment Projects.  Properties that require significant capital expenditures (generally more than 25% of acquisition cost or existing basis) to achieve stabilization or to change the use of the properties.

Rehabilitation Hospitals (“Rehab”).  Rehabilitation hospitals provide inpatient and outpatient care for patients who have sustained traumatic injuries or illnesses, such as spinal cord injuries, strokes, head injuries, orthopedic problems, work-related disabilities and neurological diseases.

Rental and RIDEA Revenues.  Represents rental and related revenues, tenant recoveries, resident fees and services, and income from direct financing leases.

Retention Rate.  Represents the ratio of total renewed square feet to the total square feet expiring and available for lease, excluding the square feet for tenant leases terminated for default or buy-out prior to the expiration of their lease.

RIDEA.  The Housing and Economic Recovery Act of 2008 (commonly referred to as “RIDEA”).

Same Period Rent.  The base rent plus additional rent due to the Company over the most recent trailing twelve-month period as of period end.  The Company uses Same Period Rent for purposes of determining property-level Cash Flow Coverage.

Same Property Portfolio (“SPP”).  Same property statistics allow management to evaluate the performance of the Company’s real estate portfolio under a consistent population, which eliminates the changes in the composition of the Company’s portfolio of properties. The Company identifies its same property portfolio as stabilized properties that are, and remained, in operations for the duration of the year-over-year comparison periods presented.  Accordingly, it takes a stabilized property a minimum of 12 months in operations to be included in the Company’s same property portfolio.  SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis.

Secured Debt Ratio.Total Secured Debt divided by Total Gross Assets. The Company believes that its Secured Debt Ratio is a meaningful supplemental measure of its financial position, which enables both management and investors to analyze its leverage and to compare its leverage to that of other companies. The Company believes that the ratio of consolidated secured debt to consolidated gross assets is the most directly comparable GAAP measure to Secured Debt Ratio. The Company’s computation of its Secured Debt Ratio may not be identical to the computations of Secured Debt Ratio reported by other companies. The Company’s share of total secured debt is not intended to reflect its actual liability or ability to access assets should there be a default under any or all of such loans or a liquidation of the joint ventures. The Company has provided reconciliations of this measure to the most comparable GAAP measure in this supplemental information package and for certain historical trend information on page 6, such reconciliations are available in the Company’s Current Reports on Form 8-K filed with the SEC dated February 15, 2011 (2010 metrics), February 12, 2010 (2009 metrics), February 10, 2009 (2008 metrics), February 11, 2008 (2008 and 2007 metrics) and July 30, 2007 (Pre-CNL Acquisition metrics).

Senior Housing.  ALFs, ILFs and CCRCs.

Specialty Hospitals.  Specialty hospitals are licensed as acute care hospitals but focus on providing care in specific areas such as cardiac, orthopedic and women’s conditions, or specific procedures such as surgery and are less likely to provide emergency services.

Square Feet.  The square footage for properties, excluding square footage for development or redevelopment properties prior to completion.

Stabilized.  Newly acquired operating assets are generally considered stabilized at the earlier of lease up (typically when the tenant(s) controls the physical use of 80% of the space) or 12 months from the acquisition date. Newly completed developments, including redevelopments, are considered stabilized at the earlier of lease-up or 24 months from the date the property is placed in service.

Total Debt.  Consolidated Debt at Book Value plus the Company’s pro rata share of debt from the Investment Management Platform.

32

Reporting Definitions and Reconciliations of Non-GAAP Measures

Total Gross Assets.  Consolidated Gross Assets plus the Company’s pro rata share of total assets from the Investment Management Platform, after adding back accumulated depreciation and amortization.

The following table details the calculation of Total Gross Assets:

In thousands
	December 31, 2011			December 31, 2010
Consolidated total assets	$	17,408,475		$	13,331,923
Investments in and advances to unconsolidated joint ventures	(224,052		)	(195,847		)
Accumulated depreciation and amortization	1,674,206			1,440,988
Accumulated depreciation and amortization from assets held for sale	—			5,146
Consolidated gross assets	$	18,858,629		$	14,582,210
HCP’s share of unconsolidated total assets(1)	269,606			515,182
HCP’s share of unconsolidated accumulated depreciation and amortization(1)	40,104			71,977
Total gross assets	$	19,168,339		$	15,169,369

Total Market Capitalization.  Total Debt plus Total Market Equity.

Total Market Equity.  The total number of outstanding shares of the Company’s common stock multiplied by the closing price per share of its common stock on the New York Stock Exchange as of period end, plus the total number of convertible partnership units multiplied by the closing price per share of its common stock on the New York Stock Exchange as of period end (adjusted for stock splits), plus the total number of outstanding shares of the Company’s preferred stock multiplied by the closing price of its preferred stock on the New York Stock Exchange as of period end.

Total Secured Debt.  Consolidated secured debt plus the Company’s pro rata share of mortgage debt from the Investment Management Platform.

Yield.  Yield is calculated as Net Operating Income, as adjusted, divided by total investment.  For acquisitions, initial yields are calculated as projected Net Operating Income, 12 months forward, as adjusted, as of the closing date divided by total acquisition cost.  The total acquisition cost basis includes the initial purchase price, the effects of adjusting assumed debt to market, lease intangible adjustments and all transaction costs.

(1)Reflects the Company’s pro rata share of amounts from the Investment Management Platform and its equity interest in HCR ManorCare OpCo.

33